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Abstract 
Introduction: 
For decades, p53 was researched as a single protein with alterations described as mutants. 
The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this 
perception, eloquently explaining the numerous roles p53 plays, including apoptosis, 
senescence and regeneration.  
Area covered: 
Here we summarise the p53 isoforms and their relevance to cancer to establish an 
understanding and theorise on potential applications of the isoforms in clinical practice. 
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Pertaining to the different expression of isoforms in different tumours, it is concluded that 
the clinical use of isoforms as prognostic and predictive biomarkers will be different 
depending on the cell type, the tissue origin of the tumours, the position of the TP53 
mutation and the driver-oncogene. 
 
Keywords – Apoptosis, biomarker, cancer, p53, p53 isoforms, tumour 
 
For decades, p53 was researched as a single protein with alterations described as mutants. 
The discovery of 12 human p53 isoforms expressed from 9 transcripts changed this 
perception, eloquently explaining the numerous roles p53 plays, including apoptosis, 
senescence and regeneration. Here we summarise the p53 isoforms and their relevance to 
cancer to establish an understanding and theorise on potential applications of the isoforms 
in clinical practice. Pertaining to the different expression of isoforms in different tumours, it 
is concluded that the clinical use of isoforms as prognostic and predictive biomarkers will be 
different depending on the cell type and tissue origin of the tumours. 
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1- Introduction to p53 and the concept of isoforms 
 
The protein 53 (p53; canonical p53), initially discovered in 1979 and often termed the 
“Guardian of the Genome” for its role in regulating cell division and arresting the formation 
of tumours, is no exception to the concept of “One gene, many proteins.”  Like most genes 
within the human genome, the TP53 gene is subject to “alternative splicing, alternative 
initiation of translation, and alternative promoter usage,” {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1177/1947601911408893", 
"ISBN" : "1947-6027 (Electronic)\\r1947-6019 (Linking)", "ISSN" : "1947-6019", "PMID" : 
"21779513", "abstract" : "Normal function of the p53 pathway is ubiquitously lost in cancers 
either through mutation or inactivating interaction with viral or cellular proteins. However, 
it is difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
manner. In this review, we summarize our current knowledge about the biological activities 
of p53 isoforms and propose a molecular mechanism conciliating our current knowledge on 
p53 and integrating p63 and p73 isoforms in the p53 pathway.", "author" : [ { "dropping-
particle" : "", "family" : "Khoury", "given" : "M. P.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", "given" : "J.-C.", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Genes 
& Cancer", "id" : "ITEM-1", "issue" : "4", "issued" : { "date-parts" : [ [ "2011" ] ] }, "page" : 
"453-465", "title" : "p53 Isoforms: An Intracellular Microprocessor?", "type" : "article-
journal", "volume" : "2" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=9d530c4a-b7e0-4241-a1b4-7a5bc16f78ad" 
] } ], "mendeley" : { "formattedCitation" : "(1)", "plainTextFormattedCitation" : "(1)", 
"previouslyFormattedCitation" : "(1)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} a 
process resulting in at least 12 different p53 protein isoforms being differentially expressed 
from 9 mRNA transcripts. This is an important notion to grasp; neatly explaining the 
extensive role that p53 plays in maintaining cell integrity and tissue function.  Moreover p53 
is subject to various post-translational modifications (phosphorylation, acetylation, 
methylation, ubiquitination,...). Different types of p53-activating stimuli may elicit different 
types of modification (2). 
 
1.1 The Gene 
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Human TP53 has the cytogenetic location 17p13.1. This alludes to chromosome 17, with (p) 
referencing the short arm of said chromosome, on position 13.1 ,  according to  human 
reference genome GRCh38 (3).The gene itself is highly conserved and is composed of 11 
exons –with a large intron between exon 1 and exon 2. To a molecular level, the gene spans 
19,148 base pairs on chromosome 17, from base pairs 7,661,779 to 7,687,550. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "URL" : 
"https://ghr.nlm.nih.gov/gene/TP53#", "accessed" : { "date-parts" : [ [ "2017", "7", "5" ] ] }, 
"container-title" : "Genetic Home Referencing", "id" : "ITEM-1", "issued" : { "date-parts" : [ [ 
"2015" ] ] }, "title" : "TP53 Gene", "type" : "webpage" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=fb5bf47c-7d79-46cc-b45a-d294289e6350" ] 
} ], "mendeley" : { "formattedCitation" : "(2)", "plainTextFormattedCitation" : "(2)", 
"previouslyFormattedCitation" : "(2)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
 
1.2 Structure of full-length p53 protein (p53, FLp53; canonical p53; p53)  
 
Full-length p53 protein structurally spans 393 amino acids and is loosely divided into 7 
functional domains [Figure 1] {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1101/cshperspect.a026039", "ISSN" : "21571422", "PMID" : 
"26801896", "abstract" : "It is poorly understood how a single protein, p53, can be 
responsive to so many stress signals and orchestrates very diverse cell responses to 
maintain/restore cell/tissue functions. The uncovering that TP53 gene physiologically 
expresses, in a tissue-dependent manner, several p53 splice variants (isoforms) provides an 
explanation to its pleiotropic biological activities. Here, we summarize a decade of research 
on p53 isoforms. The clinical studies and the diverse cellular and animal models of p53 
isoforms (zebrafish, Drosophila, and mouse) lead us to realize that a p53-mediated cell 
response is, in fact, the sum of the intrinsic activities of the coexpressed p53 isoforms and 
that unbalancing expression of different p53 isoforms leads to cancer, premature aging, 
(neuro)degenerative diseases, inflammation, embryo malformations, or defects in tissue 
regeneration. Cracking the p53 isoforms' code is, thus, a necessary step to improve cancer 
treatment. It also opens new exciting perspectives in tissue regeneration.", "author" : [ { 
"dropping-particle" : "", "family" : "Joruiz", "given" : "Sebastien M.", "non-dropping-particle" 
: "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", 
"given" : "Jean Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } 
], "container-title" : "Cold Spring Harbor Perspectives in Medicine", "id" : "ITEM-1", "issue" : 
"8", "issued" : { "date-parts" : [ [ "2016" ] ] }, "title" : "P53 isoforms: Key regulators of the cell 
fate decision", "type" : "article-journal", "volume" : "6" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=3fcefb35-42f2-4b37-b4d0-eea9a44802c3" ] 
}, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1101/cshperspect.a000927", "ISBN" : "1943-
0264", "ISSN" : "19430264", "PMID" : "20300206", "abstract" : "p53 is a transcription factor 
with a key role in the maintenance of genetic stability and therefore preventing cancer 
formation. It belongs to a family of genes composed of p53, p63, and p73. The p63 and p73 
genes have a dual gene structure with an internal promoter in intron-3 and together with 
alternative splicing, can express 6 and 29 mRNA variants, respectively. Such a complex 
expression pattern had not been previously described for the p53 gene, which was not 
consistent with our understanding of the evolution of the p53 gene family. Consequently, 
we revisited the human p53 gene structure and established that it encodes nine different 
 {PAGE  } 
p53 protein isoforms because of alternative splicing, alternative promoter usage, and 
alternative initiation sites of translation. Therefore, the human p53 gene family (p53, p63, 
and p73) has a dual gene structure. We determined that the dual gene structure is 
conserved in Drosophila and in zebrafish p53 genes. The conservation through evolution of 
the dual gene structure suggests that the p53 isoforms play an important role in p53 tumor-
suppressor activity. We and others have established that the p53 isoforms can regulate cell-
fate outcome in response to stress, by modulating p53 transcriptional activity in a promoter 
and stress-dependent manner. We have also shown that the p53 isoforms are abnormally 
expressed in several types of human cancers, suggesting that they play an important role in 
cancer formation. The determination of p53 isoforms' expression may help to link clinical 
outcome to p53 status and to improve cancer patient treatment.", "author" : [ { "dropping-
particle" : "", "family" : "Khoury", "given" : "Marie P.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", "given" : "Jean 
Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-
title" : "Cold Spring Harbor perspectives in biology", "id" : "ITEM-2", "issue" : "3", "issued" : { 
"date-parts" : [ [ "2010" ] ] }, "title" : "The isoforms of the p53 protein.", "type" : "article", 
"volume" : "2" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=f4bbbf5c-e510-
461e-9f38-7cb50a53d2e3" ] }, { "id" : "ITEM-3", "itemData" : { "DOI" : 
"10.1074/jbc.M005676200", "ISBN" : "0021-9258", "ISSN" : "00219258", "PMID" : 
"10982799", "abstract" : "The p53 protein contains several functional domains necessary for 
inducing cell cycle arrest and apoptosis. The C-terminal basic domain within residues 364-
393 and the proline-rich domain within residues 64-91 are required for apoptotic activity. In 
addition, activation domain 2 within residues 43-63 is necessary for apoptotic activity when 
the N-terminal activation domain 1 within residues 1-42 is deleted (DeltaAD1) or mutated 
(AD1(-)). Here we have discovered that an activation domain 2 mutation at residues 53-54 
(AD2(-)) abrogates the apoptotic activity but has no significant effect on cell cycle arrest. We 
have also found that p53-(DeltaAD2), which lacks activation domain 2, is inert in inducing 
apoptosis. p53-(AD2(-)DeltaBD), which is defective in activation domain 2 and lacks the C-
terminal basic domain, p53-(DeltaAD2DeltaBD), which lacks both activation domain 2 and 
the C-terminal basic domain, and p53-(DeltaPRDDeltaBD), which lacks both the proline-rich 
domain and the C-terminal basic domain, are also inert in inducing apoptosis. All four 
mutants are still capable of inducing cell cycle arrest, albeit to a lesser extent than wild-type 
p53. Interestingly, we have found that deletion of the N-terminal activation domain 1 
alleviates the requirement of the C-terminal basic domain for apoptotic activity. Thus, we 
have generated a small but potent p53-(DeltaAD1DeltaBD) molecule. Furthermore, we have 
determined that at least two of the three domains (activation domain 1, activation domain 
2, and the proline-rich domain), are required for inducing cell cycle arrest. Taken together, 
our results suggest that activation domain 2 and the proline-rich domain form an activation 
domain for inducing pro-apoptotic genes or inhibiting anti-apoptotic genes. The C-terminal 
basic domain is required for maintaining this activation domain competent for 
transactivation or transrepression.", "author" : [ { "dropping-particle" : "", "family" : "Zhu", 
"given" : "Jianhui", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Zhang", "given" : "Shunzhen", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Jiang", "given" : 
"Jieyuan", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Chen", "given" : "Xinbin", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" } ], "container-title" : "Journal of Biological Chemistry", "id" : 
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"ITEM-3", "issue" : "51", "issued" : { "date-parts" : [ [ "2000" ] ] }, "page" : "39927-39934", 
"title" : "Definition of the p53 functional domains necessary for inducing apoptosis", "type" : 
"article-journal", "volume" : "275" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=02990603-fc1b-4d6b-b4e5-98ce02e502e5" 
] } ], "mendeley" : { "formattedCitation" : "(3\u20135)", "plainTextFormattedCitation" : 
"(3\u20135)", "previouslyFormattedCitation" : "(3\u20135)" }, "properties" : { "noteIndex" : 
0 }, "schema" : "https://github.com/citation-style-language/schema/raw/master/csl-
citation.json" }}: 
 
1. Transactivation Domain 1 (TAD1; AD1) 
2. Transactivation Domain 2 (TAD2) 
 
Initially, it was thought that only one TA domain existed within FLp53; however 
further investigation revealed the presence of two transactivation subdomains – 
TAD1 existing between amino acid 1 – 42 and TAD2, a subdomain existing between 
43 and 63. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : 
{ "DOI" : "10.1074/jbc.273.21.13030", "ISBN" : "0021-9258 (Print)\\r0021-9258 
(Linking)", "ISSN" : "00219258", "PMID" : "9582339", "abstract" : "The ability of p53 
to induce apoptosis requires its sequence-specific DNA binding activity; however, 
the transactivation-deficient p53(Gln22-Ser23) can still induce apoptosis. Previously, 
we have shown that the region between residues 23 and 97 in p53 is necessary for 
such activity. In an effort to more precisely map a domain necessary for apoptosis 
within the N terminus, we found that deletion of the N-terminal 23 amino acids 
compromises, but does not abolish, p53 induction of apoptosis. Surprisingly, 
p53(Delta1-42), which lacks the N-terminal 42 amino acids and the previously 
defined activation domain, retains the ability to induce apoptosis to an even higher 
level than wild-type p53. A more extensive deletion, which eliminates the N-
terminal 63 amino acids, renders p53 completely inert in mediating apoptosis. In 
addition, we found that both p53(Delta1-42) and p53(Gln22-Ser23) can activate a 
subset of cellular p53 targets. Furthermore, we showed that residues 53 and 54 are 
critical for the apoptotic and transcriptional activities of both p53(Delta1-42) and 
p53(Gln22-Ser23). Taken together, these data suggest that within residues 43-63 lie 
an apoptotic domain as well as another transcriptional activation domain. We 
therefore postulate that the apoptotic activity in p53(Gln22-Ser23) and p53(Delta1-
42) is still transcription-dependent.", "author" : [ { "dropping-particle" : "", "family" : 
"Zhu", "given" : "Jianhui", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Zhou", "given" : "Wenjing", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Jiang", "given" : "Jieyuan", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Chen", "given" : "Xinbin", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Journal of Biological Chemistry", "id" : "ITEM-1", "issue" : "21", "issued" : { "date-
parts" : [ [ "1998" ] ] }, "page" : "13030-13036", "title" : "Identification of a novel p53 
functional domain that is necessary for mediating apoptosis", "type" : "article-
journal", "volume" : "273" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=dfd2f8f2-e561-4b4f-a0bb-
101b5ef7bb78" ] }, { "id" : "ITEM-2", "itemData" : { "DOI" : 
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"10.1038/sj.onc.1201244", "ISBN" : "0950-9232 (Print)", "ISSN" : "0950-9232", 
"PMID" : "9266967", "abstract" : "The ability of p53 to function as a tumor 
suppressor is linked to its function as a transcriptional activator, since p53 mutants 
that do not transactivate are unable to suppress tumor cell growth. Previous studies 
identified an activation domain in the amino terminal 40 residues of the protein, a 
region that binds to several general transcription factors and to some oncogene 
products. For example, mdm-2, a cellular oncoprotein, binds to this region and 
represses p53 transactivation. Here we describe a new activation domain within the 
amino terminus of p53 that maps between amino acids 40-83, and whose residues 
trp-53 and phe-54 are critical for function both in yeast and in mammalian cells. In 
vivo studies in yeast show that the new activation subdomain, unlike the previously 
described, is mdm-2 independent. Both p53 activation subdomains (1-40 and 40-83) 
require the yeast adaptor complex ADA2/ADA3/GCN5 for transcriptional activation. 
Moreover, since activation by p53 requires GCN5's enzymatic histone 
acetyltransferase domain, p53 may regulate gene expression by influencing 
chromatin modification.", "author" : [ { "dropping-particle" : "", "family" : "Candau", 
"given" : "R", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Scolnick", "given" : "D M", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Darpino", "given" : "P", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Ying", "given" : "C Y", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Halazonetis", "given" : "T D", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Berger", "given" : "S L", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Oncogene", "id" : "ITEM-2", "issue" : "7", "issued" : { "date-parts" : [ [ "1997" ] ] }, 
"page" : "807-16", "title" : "Two tandem and independent sub-activation domains in 
the amino terminus of p53 require the adaptor complex for activity.", "type" : 
"article-journal", "volume" : "15" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=bba2810e-06d0-4579-ba6a-
aa5e22bb5e7a" ] } ], "mendeley" : { "formattedCitation" : "(6,7)", 
"plainTextFormattedCitation" : "(6,7)", "previouslyFormattedCitation" : "(6,7)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} TAD1 plays a central role in 
controlling the transcription of several genes; an example being the ability to 
interact with TBP (TATA-Binding protein) in order to activate transcription. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1074/jbc.270.42.25014", "ISBN" : "0021-9258 (Print) 0021-9258 (Linking)", 
"ISSN" : "00219258", "PMID" : "7559631", "abstract" : "Tumor suppressor protein 
p53 is a potent transcriptional activator and regulates cell growth negatively. To 
characterize the transcriptional activation domain (TAD) of p53, various point 
mutants were constructed in the context of Gal4 DNA binding domain and tested 
for their transactivation ability. Our results demonstrated that the positionally 
conserved hydrophobic residues shared with herpes simplex virus VP16 and other 
transactivators are essential for transactivation. Also, the negatively charged 
residues and proline residues are necessary for full activity, but not essential for the 
activity of p53 TAD. Deletion analyses showed that p53 TAD can be divided into two 
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subdomains, amino acids 1-40 and 43-73. An in vitro glutathione S-transferase pull-
down assay establishes a linear correlation between p53 TAD-mediated 
transactivation in vivo and the binding activity of p53 TAD to TATA-binding protein 
(TBP) in vitro. Mutations that diminish the transactivation ability of Gal4-p53 TAD 
also impair the binding activity to TBP severely. Our results suggest that at least TBP 
is a direct target for p53 TAD and that the binding strength of TAD to TBP (TFIID) is 
an important parameter controlling activity of p53 TAD. In addition, circular 
dichroism spectroscopy has shown that p53 TAD peptide lacks any regular 
secondary structure in solution and that there is no significant difference between 
the spectra of the wild type TAD and that of the transactivation deficient mutant 
type.", "author" : [ { "dropping-particle" : "", "family" : "Chang", "given" : "J.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Kim", "given" : "D. H.", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Seung Woo Lee", "given" : 
"", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Kwan Yong Choi", "given" : "", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Young Chul 
Sung", "given" : "", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } 
], "container-title" : "Journal of Biological Chemistry", "id" : "ITEM-1", "issue" : "42", 
"issued" : { "date-parts" : [ [ "1995" ] ] }, "page" : "25014-25019", "title" : 
"Transactivation ability of p53 transcriptional activation domain is directly related to 
the binding affinity to TATA-binding protein", "type" : "article-journal", "volume" : 
"270" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=bf129568-5df0-
4f70-bf95-0715ccc5d617" ] } ], "mendeley" : { "formattedCitation" : "(8)", 
"plainTextFormattedCitation" : "(8)", "previouslyFormattedCitation" : "(8)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} The function of TAD2 is 
hypothesised to be more pro apoptotic in nature – in the words of Zhu et al, it 
“regulates a subset of cellular p53 targets that are responsible for apoptosis.” 
{ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1074/jbc.273.21.13030", "ISBN" : "0021-9258 (Print)\\r0021-9258 (Linking)", 
"ISSN" : "00219258", "PMID" : "9582339", "abstract" : "The ability of p53 to induce 
apoptosis requires its sequence-specific DNA binding activity; however, the 
transactivation-deficient p53(Gln22-Ser23) can still induce apoptosis. Previously, we 
have shown that the region between residues 23 and 97 in p53 is necessary for such 
activity. In an effort to more precisely map a domain necessary for apoptosis within 
the N terminus, we found that deletion of the N-terminal 23 amino acids 
compromises, but does not abolish, p53 induction of apoptosis. Surprisingly, 
p53(Delta1-42), which lacks the N-terminal 42 amino acids and the previously 
defined activation domain, retains the ability to induce apoptosis to an even higher 
level than wild-type p53. A more extensive deletion, which eliminates the N-
terminal 63 amino acids, renders p53 completely inert in mediating apoptosis. In 
addition, we found that both p53(Delta1-42) and p53(Gln22-Ser23) can activate a 
subset of cellular p53 targets. Furthermore, we showed that residues 53 and 54 are 
critical for the apoptotic and transcriptional activities of both p53(Delta1-42) and 
p53(Gln22-Ser23). Taken together, these data suggest that within residues 43-63 lie 
an apoptotic domain as well as another transcriptional activation domain. We 
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therefore postulate that the apoptotic activity in p53(Gln22-Ser23) and p53(Delta1-
42) is still transcription-dependent.", "author" : [ { "dropping-particle" : "", "family" : 
"Zhu", "given" : "Jianhui", "non-dropping-particle" : "", "parse-names" : false, 
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functional domain that is necessary for mediating apoptosis", "type" : "article-
journal", "volume" : "273" }, "uris" : [ 
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101b5ef7bb78" ] } ], "mendeley" : { "formattedCitation" : "(6)", 
"plainTextFormattedCitation" : "(6)", "previouslyFormattedCitation" : "(6)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
3. Proline Domain (PRD) 
 
The proline domain extends 27 amino acids, from residue 64 to residue 91. The 
domain is essential in inhibiting transcription – Venot et al. describes how mutated 
FLp53 lacking the proline domain does not inhibit transcription as effectively as WT 
FLp53. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1093/emboj/17.16.4668", "ISBN" : "0261-4189 (Print)", "ISSN" : 
"02614189", "PMID" : "9707426", "abstract" : "Wild-type p53 is a tumor suppressor 
gene which can activate or repress transcription, as well as induce apoptosis. The 
human p53 proline-rich domain localized between amino acids 64 and 92 has been 
reported to be necessary for efficient growth suppression. This study shows that 
this property mainly results from impaired apoptotic activity. Although deletion of 
the proline-rich domain does not affect transactivation of several promoters, such 
as WAF1, MDM2 and BAX, it does alter transcriptional repression, reactive oxygen 
species production and sequence-specific transactivation of the PIG3 gene, and 
these are activities which affect apoptosis. Whereas gel retardation assays revealed 
that this domain did not alter in vitro the specific binding to the p53-responsive 
element of PIG3, this domain plays a critical role in transactivation from a synthetic 
promoter containing this element. To explain this discrepancy, evidence is given for 
a proline-rich domain-mediated cellular activation of p53 DNA binding.", "author" : [ 
{ "dropping-particle" : "", "family" : "Venot", "given" : "Corinne", "non-dropping-
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particle" : "", "family" : "Conseiller", "given" : "Emmanuel", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bracco", 
"given" : "Laurent", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, 
{ "dropping-particle" : "", "family" : "Debussche", "given" : "Laurent", "non-
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dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"EMBO Journal", "id" : "ITEM-1", "issue" : "16", "issued" : { "date-parts" : [ [ "1998" ] 
] }, "page" : "4668-4679", "title" : "The requirement for the p53 proline-rich 
functional domain for mediation of apoptosis is correlated with specific PIG3 gene 
transactivation and with transcriptional repression", "type" : "article-journal", 
"volume" : "17" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=d3924930-d5dd-4de4-ab4e-
6496f8f13b33" ] } ], "mendeley" : { "formattedCitation" : "(9)", 
"plainTextFormattedCitation" : "(9)", "previouslyFormattedCitation" : "(9)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} Other functions include being an 
important domain in the regulation of apoptosis. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1074/jbc.M005676200", "ISBN" : "0021-9258", "ISSN" : "00219258", "PMID" : 
"10982799", "abstract" : "The p53 protein contains several functional domains 
necessary for inducing cell cycle arrest and apoptosis. The C-terminal basic domain 
within residues 364-393 and the proline-rich domain within residues 64-91 are 
required for apoptotic activity. In addition, activation domain 2 within residues 43-
63 is necessary for apoptotic activity when the N-terminal activation domain 1 
within residues 1-42 is deleted (DeltaAD1) or mutated (AD1(-)). Here we have 
discovered that an activation domain 2 mutation at residues 53-54 (AD2(-)) 
abrogates the apoptotic activity but has no significant effect on cell cycle arrest. We 
have also found that p53-(DeltaAD2), which lacks activation domain 2, is inert in 
inducing apoptosis. p53-(AD2(-)DeltaBD), which is defective in activation domain 2 
and lacks the C-terminal basic domain, p53-(DeltaAD2DeltaBD), which lacks both 
activation domain 2 and the C-terminal basic domain, and p53-(DeltaPRDDeltaBD), 
which lacks both the proline-rich domain and the C-terminal basic domain, are also 
inert in inducing apoptosis. All four mutants are still capable of inducing cell cycle 
arrest, albeit to a lesser extent than wild-type p53. Interestingly, we have found that 
deletion of the N-terminal activation domain 1 alleviates the requirement of the C-
terminal basic domain for apoptotic activity. Thus, we have generated a small but 
potent p53-(DeltaAD1DeltaBD) molecule. Furthermore, we have determined that at 
least two of the three domains (activation domain 1, activation domain 2, and the 
proline-rich domain), are required for inducing cell cycle arrest. Taken together, our 
results suggest that activation domain 2 and the proline-rich domain form an 
activation domain for inducing pro-apoptotic genes or inhibiting anti-apoptotic 
genes. The C-terminal basic domain is required for maintaining this activation 
domain competent for transactivation or transrepression.", "author" : [ { "dropping-
particle" : "", "family" : "Zhu", "given" : "Jianhui", "non-dropping-particle" : "", 
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"title" : "Definition of the p53 functional domains necessary for inducing apoptosis", 
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"type" : "article-journal", "volume" : "275" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=02990603-fc1b-4d6b-b4e5-
98ce02e502e5" ] } ], "mendeley" : { "formattedCitation" : "(5)", 
"plainTextFormattedCitation" : "(5)", "previouslyFormattedCitation" : "(5)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
4. DNA Binding Domain (DBD)  
 
The DBD is located within the central region of the p53 protein, loosely between 
amino acids 102 and 292. Structurally, the DBD consists of “two anti – parallel  
sheets that have four and five  strands,” {ADDIN CSL_CITATION { "citationItems" : [ 
{ "id" : "ITEM-1", "itemData" : { "DOI" : "10.1126/science.8023157", "ISBN" : "0036-
8075 (Print)\\r0036-8075 (Linking)", "ISSN" : "0036-8075", "PMID" : "8023157", 
"abstract" : "Mutations in the p53 tumor suppressor are the most frequently 
observed genetic alterations in human cancer. The majority of the mutations occur 
in the core domain which contains the sequence-specific DNA binding activity of the 
p53 protein (residues 102-292), and they result in loss of DNA binding. The crystal 
structure of a complex containing the core domain of human p53 and a DNA binding 
site has been determined at 2.2 angstroms resolution and refined to a 
crystallographic R factor of 20.5 percent. The core domain structure consists of a 
beta sandwich that serves as a scaffold for two large loops and a loop-sheet-helix 
motif. The two loops, which are held together in part by a tetrahedrally coordinated 
zinc atom, and the loop-sheet-helix motif form the DNA binding surface of p53. 
Residues from the loop-sheet-helix motif interact in the major groove of the DNA, 
while an arginine from one of the two large loops interacts in the minor groove. The 
loops and the loop-sheet-helix motif consist of the conserved regions of the core 
domain and contain the majority of the p53 mutations identified in tumors. The 
structure supports the hypothesis that DNA binding is critical for the biological 
activity of p53, and provides a framework for understanding how mutations 
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"uris" : [ "http://www.mendeley.com/documents/?uuid=ef6e1eef-b0f0-4161-bf37-
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"plainTextFormattedCitation" : "(10)", "previouslyFormattedCitation" : "(10)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} which supports three  - helical 
loops. Between loops L2 and L3 lies a zinc atom, stabilising the structure of this 
domain.  Discovered through the ability of the DBD to withstand proteolysis {ADDIN 
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"10.1101/gad.7.12b.2556", "ISBN" : "0890-9369 (Print)\\r0890-9369 (Linking)", 
"ISSN" : "08909369", "PMID" : "8276238", "abstract" : "Mutations in the p53 tumor 
suppressor gene are the most commonly observed genetic alterations in human 
cancer. The majority of these mutations occur in the conserved central portion of 
the gene, but there has been little information about the function of this region. 
Using proteolytic digestion of the 393-amino-acid human p53 protein, we have 
identified a 191-amino-acid protease-resistant fragment (residues 102-292) that 
corresponds to the central portion of p53, and we show that this core fragment is 
the sequence-specific DNA-binding domain of the protein. DNA binding is inhibited 
by metal chelating agents, and we find that the core domain contains zinc. 
Proteolytic digests also reveal a 53-amino-acid carboxy-terminal domain which we 
show to be the tetramerization domain of p53.", "author" : [ { "dropping-particle" : 
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language/schema/raw/master/csl-citation.json" }}, the DBD is of great interest as it 
represents the region of p53 in which 80 – 90% of mutations occur. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1126/science.8023157", "ISBN" : "0036-8075 (Print)\\r0036-8075 (Linking)", 
"ISSN" : "0036-8075", "PMID" : "8023157", "abstract" : "Mutations in the p53 tumor 
suppressor are the most frequently observed genetic alterations in human cancer. 
The majority of the mutations occur in the core domain which contains the 
sequence-specific DNA binding activity of the p53 protein (residues 102-292), and 
they result in loss of DNA binding. The crystal structure of a complex containing the 
core domain of human p53 and a DNA binding site has been determined at 2.2 
angstroms resolution and refined to a crystallographic R factor of 20.5 percent. The 
core domain structure consists of a beta sandwich that serves as a scaffold for two 
large loops and a loop-sheet-helix motif. The two loops, which are held together in 
part by a tetrahedrally coordinated zinc atom, and the loop-sheet-helix motif form 
the DNA binding surface of p53. Residues from the loop-sheet-helix motif interact in 
the major groove of the DNA, while an arginine from one of the two large loops 
interacts in the minor groove. The loops and the loop-sheet-helix motif consist of the 
conserved regions of the core domain and contain the majority of the p53 mutations 
identified in tumors. The structure supports the hypothesis that DNA binding is 
critical for the biological activity of p53, and provides a framework for understanding 
how mutations inactivate it.", "author" : [ { "dropping-particle" : "", "family" : "Cho", 
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are the underlying cause of Li-Fraumeni syndrome, which predisposes to a wide 
spectrum of early-onset cancers. Most mutations are single-base substitutions 
distributed throughout the coding sequence. Their diverse types and positions may 
inform on the nature of mutagenic mechanisms involved in cancer etiology. TP53 
mutations are also potential prognostic and predictive markers, as well as targets for 
pharmacological intervention. All mutations found in human cancers are compiled in 
the IARC TP53 Database (http://www-p53.iarc.fr/). A human TP53 knockin mouse 
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5. Nuclear localisation signalling region (NLS) 
 
The NLS is responsible for directing the movement of p53 into the nucleus. Three 
regions exist but NLS 1, the primary NLS, is found between amino acids 313 and 322. 
{ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1128/MCB.10.12.6565", "ISBN" : "0270-7306 (Print)", "ISSN" : "0270-7306", 
"PMID" : "2247074", "abstract" : "The basic carboxy terminus of p53 plays an 
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important role in directing the protein into the nuclear compartment. The C 
terminus of the p53 molecule contains a cluster of several nuclear localization signals 
(NLSs) that mediate the migration of the protein into the cell nucleus. NLSI, the most 
active domain, is highly conserved in genetically diverged species and shares perfect 
homology with consensus NLS sequences found in other nuclear proteins. The other 
two NLSs, II and III, appear to be less effective and less conserved. Although nuclear 
localization is dictated primarily by the NLSs inherent in the primary amino acid 
sequence, the actual nuclear homing can be modified by interactions with other 
proteins expressed in the cell. Comparison between wild-type p53 and naturally 
occurring mutant p53 showed that both protein categories could migrate into the 
nucleus of rat primary embryonic fibroblasts by essentially similar mechanisms. 
Nuclear localization of both proteins was totally dependent on the existence of 
functional NLS domains. In COS cells, however, we found that NLS-deprived wild-
type p53 molecules could migrate into the nucleus by complexing with another 
nuclear protein, simian virus 40 large-T antigen. Wild-type and mutant p53 proteins 
differentially complexed with viral or cellular proteins, which may significantly affect 
the ultimate compartmentalization of p53 in the cell; this finding suggests that the 
actual subcellular compartmentalization of proteins may differ in various cell type 
milieux and may largely be affected by the ability of these proteins to complex with 
other proteins expressed in the cell. Experiments designed to test the physiological 
significance of p53 subcellular localization indicated that nuclear localization of 
mutant p53 is essential for this protein to enhance the process of malignant 
transformation of partially transformed cells, suggesting that p53 functions within 
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6. Tetramerization Domain/Oligomerization domain (TD/OD) 
 
The TD/OD is credited with p53’s capacity to form a tetramer. {ADDIN CSL_CITATION 
{ "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1073/pnas.90.8.3319", "ISBN" : "0027-8424 (Print)", "ISSN" : "0027-8424", 
"PMID" : "8475074", "abstract" : "We have analyzed the size and structure of native 
immunopurified human p53 protein. By using a combination of chemical 
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crosslinking, gel filtration chromatography, and zonal velocity gradient 
centrifugation, we have determined that the predominant form of p53 in such 
preparations is a tetramer. The behavior of purified p53 in gels and sucrose gradients 
implies that the protein has an extended shape. Wild-type p53 has been shown to 
bind specifically to sites in cellular and viral DNA. We show in this study by 
Southwestern ligand blotting and by analysis of DNA-bound crosslinked p53 that p53 
monomers, dimers, and tetramers can bind directly to DNA.", "author" : [ { 
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particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Chen", "given" : "X", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Bargonetti", "given" : "J", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Prives", "given" : "C", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" } ], "container-title" : "Proceedings of the National Academy of Sciences of the 
United States of America", "id" : "ITEM-1", "issue" : "8", "issued" : { "date-parts" : [ [ 
"1993" ] ] }, "page" : "3319-3323", "title" : "The p53 protein is an unusually shaped 
tetramer that binds directly to DNA.", "type" : "article-journal", "volume" : "90" }, 
"uris" : [ "http://www.mendeley.com/documents/?uuid=eea710ca-e465-45d8-85d8-
be8c9c92da16" ] } ], "mendeley" : { "formattedCitation" : "(14)", 
"plainTextFormattedCitation" : "(14)", "previouslyFormattedCitation" : "(14)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} p53 mutants lacking the TD are 
still able to bind p53 response element on DNA; however it is estimated to be 10 – 
100 times lower when compared to WT FLp53 {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1073/pnas.92.19.8591", "ISBN" : "0027-8424 (Print) 0027-8424 (Linking)", "ISSN" 
: "0027-8424", "PMID" : "7567980", "abstract" : "Recent structural studies of the 
minimal core DNA-binding domain of p53 (p53DBD) complexed to a single consensus 
pentamer sequence and of the isolated p53 tet-ramerization domain have provided 
valuable insights into their functions, but many questions about their interacting 
roles and synergism remain unanswered. To better under-stand these relationships, 
we have examined the binding of the p53DBD to two biologically important full-
response elements (the WAFI and ribosomal gene cluster sites) by using DNA 
circularization and analytical ultracentrifugation. We show that the p53DBD binds 
DNA strongly and cooperatively with p53DBD to DNA binding stoichiometries of 4:1. 
For the WAFI element, the mean apparent Kd is (8.3 + 1.4) x 10-8 M, and no 
intermediate species of lower stoichiometries can be de-tected. We show further 
that complex formation induces an axial bend of at least 60\u00b0 in both response 
elements. These results, taken collectively, demonstrate that p53DBD pos-sesses the 
ability to direct the formation of a tight nucleopro-tein complex having the same 4:1 
DNA-binding stoichiometry as wild-type p53 which is accompanied by a substantial 
confor-mational change in the response-element DNA. This suggests that the 
p53DBD may play a role in the tetramerization function of p53. A possible role in this 
regard is proposed.", "author" : [ { "dropping-particle" : "", "family" : 
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this domain to DNA binding. This is achieved by correcting the orientation of the p53 
protein, and mediating the twisting of DNA to allow for a precise ‘fit’ per say. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1073/pnas.96.5.1875", "ISBN" : "0027-8424 (Print)\\n0027-8424 (Linking)", 
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molecules of the DNA binding domain of human p53 (p53DBD) bind the response 
elements with high cooperativity and bend the DNA. By using A-tract phasing 
experiments, we find significant differences between the bending and twisting of 
DNA by p53DBD and by full-length human wild-type (wt) p53. Our data show that 
four subunits of p53DBD bend the DNA by 32-36 degrees, whereas wt p53 bends it 
by 51-57 degrees. The directionality of bending is consistent with major groove 
bends at the two pentamer junctions in the consensus DNA response element. More 
sophisticated phasing analyses also demonstrate that p53DBD and wt p53 overtwist 
the DNA response element by approximately 35 degrees and approximately 70 
degrees, respectively. These results are in accord with molecular modeling studies of 
the tetrameric complex. Within the constraints imposed by the protein subunits, the 
DNA can assume a range of conformations resulting from correlated changes in bend 
and twist angles such that the p53-DNA tetrameric complex is stabilized by DNA 
overtwisting and bending toward the major groove at the CATG tetramers. This 
bending is consistent with the inherent sequence-dependent anisotropy of the 
duplex. Overall, the four p53 moieties are placed laterally in a staggered array on the 
external side of the DNA loop and have numerous interprotein interactions that 
increase the stability and cooperativity of binding. The novel architecture of the p53 
tetrameric complex has important functional implications including possible p53 
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occur upon the TD, which is located between residues 326 – 355. (18) 
 
7. -Regulatory Domain / DNA Damage Recognition Domain () 
 
The -regulatory domain is a basic region located between amino acids 363 and 393, which 
is heavily modified by post-translational modification, integrating multiple cell signals and 
regulating p53 transcriptional activity and promoter specificity. (4; 19) 
 
 
 
 
 
 
 
1.3 Generalised Functions of the p53 protein 
 
Certain regions of TP53 are known to be highly conserved across species; a concept 
eloquently encapsulating the vital functions p53 pathway plays within other species as well 
as humans. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" 
: "10.1101/cshperspect.a001198", "ISBN" : "1943-0264", "ISSN" : "19430264", "PMID" : 
Figure 1 A to scale representation of the human p53 domains; the transactivation domains (TAD-1/TAD-2), the proline 
rich domain (PRD), the DNA binding domain (DBD), the nuclear localisation signal (NLS), the 
tetramerisation/oligomerisation domain (TD/OD) and the  regulatory domain (). Numerical checkpoints denote the 
final amino acid of each domain. 
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all invertebrates and first duplicates to produce a p53 gene and a p63/p73 ancestor in 
cartilaginous fish. Bony fish contain all three genes, p53, p63, and p73, and the functions of 
these three transcription factors diversify in the higher vertebrates. Thus, this gene family 
has preserved its structural features and functional activities for over one billion years of 
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biological processes, responding to a diverse number of stress signals consequentially 
leading to different cell outcomes, many of which are tumour suppressive. [Summarised in 
Figure 2] 
 
 {PAGE  } 
Canonical p53 protein has been estimated to interact directly with more than 250 proteins, 
exemplifying the diverse roles and functions it fulfils (21). It is estimated that more than 
10% of all human genes are regulated by p53 pathway (22,23).  It is therefore important to 
mention that only a few are explored in this review. 
 
 
 
 
a- Cell Cycle Arrest in Response to DNA Damage 
 
In the absence of DNA damage, canonical p53 protein is tagged for degradation by MDM2 (a 
p53-specific E3 ubiquitin ligase) or its homolog MDMX (24), regulating p53 activities.  
Upon DNA damage, MDM2 is phosphorylated, reducing its affinity for FLp53. Thus, several 
MDM2 inhibitors have been evaluated as potential novel anticancer drugs (25). FLp53 is 
stabilized and retained in the nucleus in response to cellular stress. The stabilization of 
FLp53 is dependent on a variety of proteins, including damage sensors such as ATM and 
poly-(ADP-ribose)-polymerase 1 (26-29), as well as on different p53 isoforms (1, 5).  
 
Canonical p53 can arrest the cell cycle at the G1 / S checkpoint in the presence of 
unrepaired DNA damage; a delay crucial in aiding repair mechanisms. {ADDIN CSL_CITATION 
{ "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1016/S0092-8674(00)81871-
1", "ISBN" : "0092-8674", "ISSN" : "00928674", "PMID" : "9039259", "abstract" : "The p53 
gene and its protein product have become the center of intensive study ever since it 
became clear that slightly more than 50% of human cancers contain mutations in this gene. 
An extensive database catalogs these mutations in more than 50 different cell and tissue 
types, although some types of cancers never appear to select for p53 mutations. The nature 
of these genetic changes in cancer cells is most commonly a missense mutation in one 
allele, producing a faulty protein that is then observed at high concentrations in these cells, 
followed by a reduction to homozygosity. More rarely, deletions or chain-termination 
Figure 2 – Diagrammatical presentation of the extracellular and intracellular signals which initiate 
alterations in the ratio of p53 isoforms and the subsequent p53-mediated cellular effects. Extracellular and 
intracellular signals include nucleic acid oxidation, interaction with neighbouring cells, extracellular 
environmental input and additional signals such as oncogene expression. The alterations in the p53 isoform 
ratio induce one or more of the cellular effects, including; angiogenesis, regeneration, DNA repair, 
programmed cell death and cell cycle arrest. Note that the represented input and output are not exhaustive 
but demonstrate the varied nature of both.   
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mutations in the p53 gene indicate that the null phenotype predisposes to cancer, as has 
been observed in mice with a homozygous p53 null mutation. There have been some 
suggestions that the missense mutant producing a faulty p53 protein could contribute a 
\"gain of function\" phenotype, but this remains to be substantiated by additional 
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of many genes under the control of p53; one being p21WAF1/CIP1 -  a CDK inhibitor. CDK (cyclin 
dependent kinase) complexes govern the progression of the cell cycle from G1 to S stage 
and the transition from G2 to the mitotic stage of the cell cycle. By inhibiting CDK, 
p21WAF1/CIP1 arrests the cell cycle at the G1 checkpoint).  {ADDIN CSL_CITATION { 
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pathways of retinoblastoma protein (pRB)\u2013E2F and Myc, their convergence to control 
the activity of the cyclin-dependent kinase 2 (Cdk2) at the G1/S boundary, as well as the two 
waves of checkpoint responses at G1/S: the rapid pathway(s) leading to Cdc25A 
degradation, and the delayed p53\u2013p21 cascade, both silencing the Cdk2 activity upon 
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p53 pathway also maintains control over the transition to G2 / M stage, through inhibition 
of the CDC2 gene product– Cdk1. In short, the kinase activity of the Cdk1/Cyclin B1 complex 
is required for G2 / M progression. p53 pathway can control entry into mitosis by inhibiting 
expression of CDC2 and/or Cyclin B and by inducing expression of p53 target genes such as 
14-3-3.  {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
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b. Cellular Senescence  
 
Cellular senescence occurs when cells do not progress through the cell cycle (G0), hence 
resulting in the permanent arresting of DNA replication, even if conditions permit its 
continuity. This state can be induced by p53 pathway in response to a varying number of 
signals, including telomere erosion during replication {ADDIN CSL_CITATION { 
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terminus of a DNA helix has been called its Achilles' heel. Thus to prevent possible 
incomplete replication and instability of the termini of linear DNA, eukaryotic chromosomes 
end in characteristic repetitive DNA sequences within specialized structures called 
telomeres. In immortal cells, loss of telomeric DNA due to degradation or incomplete 
replication is apparently balanced by telomere elongation, which may involve de novo 
synthesis of additional repeats by novel DNA polymerase called telomerase. Such a 
polymerase has been recently detected in HeLa cells. It has been proposed that the finite 
doubling capacity of normal mammalian cells is due to a loss of telomeric DNA and eventual 
deletion of essential sequences. In yeast, the est1 mutation causes gradual loss of telomeric 
DNA and eventual cell death mimicking senescence in higher eukaryotic cells. Here, we 
show that the amount and length of telomeric DNA in human fibroblasts does in fact 
decrease as a function of serial passage during ageing in vitro and possibly in vivo. It is not 
known whether this loss of DNA has a causal role in senescence.", "author" : [ { "dropping-
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accumulation of ROS and DNA damage.  
Studies have also revealed the expression of oncogenes can stimulate senescence – an 
example being the overproduction of pro – proliferative proteins such as E2F -1, RAF, MOS 
and BRAF.  
 
The p53 pathway for mobilising senescence is reliant on p21; the protein is recruited by 
FLp53 when DNA damage signals in particular are received. A deficiency of p21 results in the 
failure of a cell to initiate cell cycle arrest in response to radiation {ADDIN CSL_CITATION { 
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partly of p21-/- and partly of p21+/+ cells. Immunohistochemical studies of the p21+/+ and 
p21-/- components of adult small intestine indicated that deletion of p21 has no detectable 
effect on the migration-associated differentiation of the four principal intestinal epithelial 
cell lineages or on p53-dependent apoptosis following irradiation. However, p21-/- mouse 
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damage.", "author" : [ { "dropping-particle" : "", "family" : "Brugarolas", "given" : "J", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Chandrasekaran", "given" : "C", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Gordon", "given" : "J I", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Beach", "given" : "D", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Jacks", "given" : "T", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Hannon", "given" : 
"G J", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Nature", "id" : "ITEM-1", "issue" : "6549", "issued" : { "date-parts" : [ [ "1995" ] ] }, "page" : 
"552-557", "title" : "Radiation-induced cell cycle arrest compromised by p21 deficiency.", 
"type" : "article", "volume" : "377" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=c0e407c7-2242-4fa9-af40-c7d9a043c835" ] 
} ], "mendeley" : { "formattedCitation" : "(25)", "plainTextFormattedCitation" : "(25)", 
"previouslyFormattedCitation" : "(25)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}, 
 {PAGE  } 
indicating its importance in inducing cellular senescence. {ADDIN CSL_CITATION { 
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an additional response by adopting a state of permanent cell-cycle arrest that is termed 
cellular senescence. Understanding the causes and consequences of cellular senescence has 
provided novel insights into how cells react to stress, especially genotoxic stress, and how 
this cellular response can affect complex organismal processes such as the development of 
cancer and ageing.", "author" : [ { "dropping-particle" : "", "family" : "Campisi", "given" : 
"Judith", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "d'Adda di Fagagna", "given" : "Fabrizio", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" } ], "container-title" : "Nature reviews. Molecular cell 
biology", "id" : "ITEM-1", "issue" : "9", "issued" : { "date-parts" : [ [ "2007" ] ] }, "page" : 
"729-740", "title" : "Cellular senescence: when bad things happen to good cells.", "type" : 
"article-journal", "volume" : "8" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=92c4627c-4428-4229-a1d7-9e5b32ed7d90" 
] }, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1038/onc.2012.640", "ISBN" : "1476-5594 
(Electronic)\\r0950-9232 (Linking)", "ISSN" : "1476-5594", "PMID" : "23416979", "abstract" : 
"p53 functions as a transcription factor involved in cell-cycle control, DNA repair, apoptosis 
and cellular stress responses. However, besides inducing cell growth arrest and apoptosis, 
p53 activation also modulates cellular senescence and organismal aging. Senescence is an 
irreversible cell-cycle arrest that has a crucial role both in aging and as a robust physiological 
antitumor response, which counteracts oncogenic insults. Therefore, via the regulation of 
senescence, p53 contributes to tumor growth suppression, in a manner strictly dependent 
by its expression and cellular context. In this review, we focus on the recent advances on 
the contribution of p53 to cellular senescence and its implication for cancer therapy, and we 
will discuss p53's impact on animal lifespan. Moreover, we describe p53-mediated 
regulation of several physiological pathways that could mediate its role in both senescence 
and aging.", "author" : [ { "dropping-particle" : "", "family" : "Rufini", "given" : "a", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Tucci", "given" : "P", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Celardo", "given" : "I", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Melino", "given" : 
"G", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Oncogene", "id" : "ITEM-2", "issue" : "43", "issued" : { "date-parts" : [ [ "2013" ] ] }, "page" : 
"5129-43", "title" : "Senescence and aging: the critical roles of p53.", "type" : "article-
journal", "volume" : "32" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=be82a691-37f4-418b-88da-d2554ebf99dc" 
] } ], "mendeley" : { "formattedCitation" : "(26,27)", "plainTextFormattedCitation" : 
"(26,27)", "previouslyFormattedCitation" : "(26,27)" }, "properties" : { "noteIndex" : 0 }, 
"schema" : "https://github.com/citation-style-language/schema/raw/master/csl-
citation.json" }} 
 
c. Apoptosis 
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Upon DNA damage, the cell can also undergo apoptosis. Whether the cell elects for 
apoptosis or cell cycle arrest is contingent on several factors, including the cell type and the 
form of cellular stress experienced. The two most studied apoptotic signalling pathways are 
regulated by p53 pathway: the intrinsic mitochondrial pathway and the extrinsic death 
receptor pathway. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1039/b905129p", "ISBN" : "1539-6509", "ISSN" : "1944-7930", "PMID" : 
"20193641", "abstract" : "The dynamic and multiple functions of p53, together with its 
involvement in the most common non-infectious diseases, underscore the need to elucidate 
the complexity of the p53 regulatory networks. Pathological conditions such as cancer, 
neurodegeneration, ischemia, cholestasis, and atherosclerosis are all strongly associated 
with deregulated levels of apoptosis in which p53 dysfunction has a prominent role. We will 
highlight recent developments of p53-induced apoptosis in human diseases, with a focus on 
modulation of liver cell apoptosis. In addition, we will discuss controversies arising from 
widespread p53 activation as a therapeutic approach to cancer. Recent studies have 
provided relevant and unprecedented information about mechanistic antiapoptotic 
functions of the endogenous bile acid, ursodeoxycholic acid (UDCA), suggesting that the 
finely tuned, complex control of p53 by Mdm-2 (mouse double minute-2, an oncoprotein) is 
a key step in UDCA modulation of p53-triggered apoptosis. We will also review recent 
therapeutic strategies and clinical applications of targeted agents, their safety, and efficacy, 
with particular emphasis on potential benefits of UDCA.", "author" : [ { "dropping-particle" : 
"", "family" : "Amaral", "given" : "Joana D", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Xavier", "given" : "Joana M", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Steer", "given" : "Clifford J", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Rodrigues", "given" : "Cec\u00edlia M", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Discovery medicine", "id" : "ITEM-1", "issue" : "45", "issued" : { "date-parts" : [ [ "2010" ] ] }, 
"page" : "145-152", "title" : "The role of p53 in apoptosis.", "type" : "article-journal", 
"volume" : "9" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=41c60312-be58-
4990-97d3-e7fab9cf64c6" ] } ], "mendeley" : { "formattedCitation" : "(28)", 
"plainTextFormattedCitation" : "(28)", "previouslyFormattedCitation" : "(28)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
a. Intrinsic Mitochondrial Pathway 
 
This pathway involves the transcription of pro – apoptotic genes, chiefly of the Bcl-2 
family of proteins (including BAX, PUMA and NOX). Bcl-2 proteins control the release 
of cytochrome C from the mitochondria {ADDIN CSL_CITATION { "citationItems" : [ { 
"id" : "ITEM-1", "itemData" : { "DOI" : "10.1016/S0092-8674(02)01036-X", "ISBN" : 
"0092-8674 (Print)\\n0092-8674 (Linking)", "ISSN" : "00928674", "PMID" : 
"12419244", "abstract" : "Bcl-2 family proteins regulate the release of proteins like 
cytochrome c from mitochondria during apoptosis. We used cell-free systems and 
ultimately a vesicular reconstitution from defined molecules to show that outer 
membrane permeabilization by Bcl-2 family proteins requires neither the 
mitochondrial matrix, the inner membrane, nor other proteins. Bid, or its BH3-
domain peptide, activated monomeric Bax to produce membrane openings that 
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allowed the passage of very large (2 megadalton) dextran molecules, explaining the 
translocation of large mitochondrial proteins during apoptosis. This process required 
cardiolipin and was inhibited by antiapoptotic Bcl-xL. We conclude that 
mitochondrial protein release in apoptosis can be mediated by supramolecular 
openings in the outer mitochondrial membrane, promoted by BH3/Bax/lipid 
interaction and directly inhibited by Bcl-xL.", "author" : [ { "dropping-particle" : "", 
"family" : "Kuwana", "given" : "Tomomi", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Mackey", "given" : 
"Mason R.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Perkins", "given" : "Guy", "non-dropping-particle" 
: "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Ellisman", "given" : "Mark H.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Latterich", "given" : "Martin", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Schneiter", "given" : "Roger", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Green", 
"given" : "Douglas R.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Newmeyer", "given" : "Donald D.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Cell", 
"id" : "ITEM-1", "issue" : "3", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : "331-
342", "title" : "Bid, Bax, and lipids cooperate to form supramolecular openings in the 
outer mitochondrial membrane", "type" : "article-journal", "volume" : "111" }, "uris" 
: [ "http://www.mendeley.com/documents/?uuid=785a0229-8e71-4f0b-87fb-
4057d6df6112" ] } ], "mendeley" : { "formattedCitation" : "(29)", 
"plainTextFormattedCitation" : "(29)", "previouslyFormattedCitation" : "(29)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}, which in turn activates caspase – 
9 and a sequential caspase cascade that results in the destruction of the cell. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1016/S0092-8674(00)80434-1", "ISSN" : "00928674", "author" : [ { "dropping-
particle" : "", "family" : "Li", "given" : "Peng", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Nijhawan", "given" 
: "Deepak", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Budihardjo", "given" : "Imawati", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Srinivasula", "given" : "Srinivasa M", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Ahmad", "given" : 
"Manzoor", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Alnemri", "given" : "Emad S", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Wang", "given" : "Xiaodong", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" } ], "container-title" : "Cell", "id" : "ITEM-1", "issue" : "4", "issued" : { 
"date-parts" : [ [ "1997", "11" ] ] }, "page" : "479-489", "title" : "Cytochrome c and 
dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic 
Protease Cascade", "type" : "article-journal", "volume" : "91" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=c2bee90e-24cc-3cff-87eb-
2b4abc36c0bd" ] }, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1242/jcs.00739", 
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"ISBN" : "0021-9533 (Print)\\r0021-9533 (Linking)", "ISSN" : "0021-9533", "PMID" : 
"12972501", "abstract" : "Exposure to cellular stress can trigger the p53 tumor 
suppressor, a sequence-specific transcription factor, to induce cell growth arrest or 
apoptosis. The choice between these cellular responses is influenced by many 
factors, including the type of cell and stress, and the action of p53 co-activators. p53 
stimulates a wide network of signals that act through two major apoptotic pathways. 
The extrinsic, death receptor pathway triggers the activation of a caspase cascade, 
and the intrinsic, mitochondrial pathway shifts the balance in the Bcl-2 family 
towards the pro-apoptotic members, promoting the formation of the apoptosome, 
and consequently caspase-mediated apoptosis. The impact of these two apoptotic 
pathways may be enhanced when they converge through Bid, which is a p53 target. 
The majority of these apoptotic effects are mediated through the induction of 
specific apoptotic target genes. However, p53 can also promote apoptosis by a 
transcription-independent mechanism under certain conditions. Thus, a multitude of 
mechanisms are employed by p53 to ensure efficient induction of apoptosis in a 
stage-, tissue- and stress-signal-specific manner. Manipulation of the apoptotic 
functions of p53 constitutes an attractive target for cancer therapy.", "author" : [ { 
"dropping-particle" : "", "family" : "Haupt", "given" : "Susan", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Berger", "given" : "Michael", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Goldberg", "given" : "Zehavit", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Haupt", "given" : "Ygal", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" } ], "container-title" : "Journal of cell science", "id" : 
"ITEM-2", "issue" : "Pt 20", "issued" : { "date-parts" : [ [ "2003" ] ] }, "page" : "4077-
85", "title" : "Apoptosis - the p53 network.", "type" : "article-journal", "volume" : 
"116" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=8ec1ee91-ede7-
4fdd-8db0-00797104a582" ] } ], "mendeley" : { "formattedCitation" : "(30,31)", 
"plainTextFormattedCitation" : "(30,31)", "previouslyFormattedCitation" : "(30,31)" 
}, "properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}  
 
b. Extrinsic Death Receptor Pathway 
 
p53 pathway can also stimulate the apoptotic pathway through the activation of 
genes encoding three proteins in particular: Fas, DR5 (Trail) and PERP. 
Fas, when bound to FasL (its ligand), prompts the release of caspases {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1126/science.7533326", "ISBN" : "0036-8075 (Print)\\n0036-8075 (Linking)", 
"ISSN" : "0036-8075", "PMID" : "7533326", "abstract" : "Fas ligand (FasL), a cell 
surface molecule belonging to the tumor necrosis factor family, binds to its receptor 
Fas, thus inducing apoptosis of Fas-bearing cells. Various cells express Fas, whereas 
FasL is expressed predominantly in activated T cells. In the immune system, Fas and 
FasL are involved in down-regulation of immune reactions as well as in T cell-
mediated cytotoxicity. Malfunction of the Fas system causes lymphoproliferative 
disorders and accelerates autoimmune diseases, whereas its exacerbation may 
cause tissue destruction.", "author" : [ { "dropping-particle" : "", "family" : "Nagata", 
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"given" : "S", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Golstein", "given" : "P", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" } ], "container-title" : "Science (New York, 
N.Y.)", "id" : "ITEM-1", "issue" : "5203", "issued" : { "date-parts" : [ [ "1995" ] ] }, 
"page" : "1449-1456", "title" : "The Fas death factor.", "type" : "article-journal", 
"volume" : "267" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=396ec846-2dba-4ca5-9165-
c62d7af88a45" ] } ], "mendeley" : { "formattedCitation" : "(32)", 
"plainTextFormattedCitation" : "(32)", "previouslyFormattedCitation" : "(32)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} leading to the degradation of the 
cell. The expression of Fas often occurs in response to gamma radiation. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1038/sj.onc.1203366", "ISSN" : "09509232", "PMID" : "10698510", "abstract" : 
"The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-
ordinate the adaptive response to genotoxic stress is poorly understood. p53 has 
been shown to transactivate several genes that could be involved in two main 
cellular responses, growth arrest and apoptosis. To get further insight into the 
tissue-specific regulation of p53 transcriptional activity, we performed an extensive 
study looking at the expression of four well characterized p53-responsive genes, 
before and after gamma-irradiation in p53 wild-type (p53+/+) and p53-deficient 
(p53-/-) mice. The waf1, bax, fas and mdm2 genes were chosen for their different 
potential roles in the cellular response to stress. Our data demonstrate the strict 
p53-dependence of mRNA up-regulation for bax, fas and mdm2 in irradiated tissues 
and confirm such findings for waf1. They further highlight complex levels of 
regulatory mechanisms that could lead, in vivo, to selective transcriptional activation 
of genes by p53. In addition, our results provide arguments for the involvement of 
p53 in the basal mRNA expression of the four genes in some organs. Finally, in situ 
expression of Bax and p21Waf-1 protein suggests, at least in lymphoid organs, a 
direct correlation between selective p53-target gene expression and a particular 
response of a cell to ionising radiation.", "author" : [ { "dropping-particle" : "", 
"family" : "Bouvard", "given" : "V\u00e9ronique", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Zaitchouk", 
"given" : "Tatiana", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, 
{ "dropping-particle" : "", "family" : "Vacher", "given" : "Monique", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Duthu", "given" : "Arlette", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Canivet", "given" : "Martine", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Choisy-Rossi", "given" : "Caroline", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Nieruchalski", "given" : "Myriam", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "May", "given" : "Evelyne", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Oncogene", "id" : "ITEM-1", "issue" : "5", "issued" : { "date-parts" : [ [ "2000", "2", 
"17" ] ] }, "page" : "649-660", "title" : "Tissue and cell-specific expression of the p53-
target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation 
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in mice", "type" : "article-journal", "volume" : "19" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=a6aa6051-a569-3632-8c72-
74ad48f1e822" ] } ], "mendeley" : { "formattedCitation" : "(33)", 
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language/schema/raw/master/csl-citation.json" }} DR5 promotes cell death through 
the activation of caspase – 8, leading to a similar cascade. PERP is suggested to be 
directly associated with p53, possibly cooperating with activated E2F-1 which 
contributes to apoptosis. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1242/jcs.00739", "ISBN" : "0021-9533 (Print)\\r0021-9533 
(Linking)", "ISSN" : "0021-9533", "PMID" : "12972501", "abstract" : "Exposure to 
cellular stress can trigger the p53 tumor suppressor, a sequence-specific 
transcription factor, to induce cell growth arrest or apoptosis. The choice between 
these cellular responses is influenced by many factors, including the type of cell and 
stress, and the action of p53 co-activators. p53 stimulates a wide network of signals 
that act through two major apoptotic pathways. The extrinsic, death receptor 
pathway triggers the activation of a caspase cascade, and the intrinsic, mitochondrial 
pathway shifts the balance in the Bcl-2 family towards the pro-apoptotic members, 
promoting the formation of the apoptosome, and consequently caspase-mediated 
apoptosis. The impact of these two apoptotic pathways may be enhanced when they 
converge through Bid, which is a p53 target. The majority of these apoptotic effects 
are mediated through the induction of specific apoptotic target genes. However, p53 
can also promote apoptosis by a transcription-independent mechanism under 
certain conditions. Thus, a multitude of mechanisms are employed by p53 to ensure 
efficient induction of apoptosis in a stage-, tissue- and stress-signal-specific manner. 
Manipulation of the apoptotic functions of p53 constitutes an attractive target for 
cancer therapy.", "author" : [ { "dropping-particle" : "", "family" : "Haupt", "given" : 
"Susan", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
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[ "2003" ] ] }, "page" : "4077-85", "title" : "Apoptosis - the p53 network.", "type" : 
"article-journal", "volume" : "116" }, "uris" : [ 
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It is presently understood that the p53-mediated acute response to DNA damage is only 
part of p53-mediated tumour suppression (46). p53 carries out 'baseline surveillance' of the 
integrity of the genome along with its acute-phase functions. The control at baseline 
involves transient fluctuations in p53 levels that are not sufficient to activate apoptosis or 
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cellular senescence, but instead target the detection and repair of the lesion. p53 also plays 
a role in innate and adaptive immune responses, including anticancer immunity. (47) 
 
2- The p53 Isoforms  
 
As mentioned, the p53 isoforms arise as a result of “alternative splicing [of introns], 
alternative initiation of translation and alternative promoter usage”. {ADDIN CSL_CITATION 
{ "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1177/1947601911408893", 
"ISBN" : "1947-6027 (Electronic)\\r1947-6019 (Linking)", "ISSN" : "1947-6019", "PMID" : 
"21779513", "abstract" : "Normal function of the p53 pathway is ubiquitously lost in cancers 
either through mutation or inactivating interaction with viral or cellular proteins. However, 
it is difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
manner. In this review, we summarize our current knowledge about the biological activities 
of p53 isoforms and propose a molecular mechanism conciliating our current knowledge on 
p53 and integrating p63 and p73 isoforms in the p53 pathway.", "author" : [ { "dropping-
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& Cancer", "id" : "ITEM-1", "issue" : "4", "issued" : { "date-parts" : [ [ "2011" ] ] }, "page" : 
"453-465", "title" : "p53 Isoforms: An Intracellular Microprocessor?", "type" : "article-
journal", "volume" : "2" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=9d530c4a-b7e0-4241-a1b4-7a5bc16f78ad" 
] } ], "mendeley" : { "formattedCitation" : "(1)", "plainTextFormattedCitation" : "(1)", 
"previouslyFormattedCitation" : "(1)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
Initially, three human p53 isoforms were described prior to the discovery of further isoforms 
in 2005 by Bourdon et al {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", 
"PMID" : "16131611", "abstract" : "The recently discovered p53-related genes, p73 and p63, 
express multiple splice variants and N-terminally truncated forms initiated from an 
alternative promoter in intron 3. To date, no alternative promoter and multiple splice 
variants have been described for the p53 gene. In this study, we show that p53 has a gene 
structure similar to the p73 and p63 genes. The human p53 gene contains an alternative 
promoter and transcribes multiple splice variants. We show that p53 variants are expressed 
in normal human tissue in a tissue-dependent manner. We determine that the alternative 
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promoter is conserved through evolution from Drosophila to man, suggesting that the p53 
family gene structure plays an essential role in the multiple activities of the p53 family 
members. Consistent with this hypothesis, p53 variants are differentially expressed in 
human breast tumors compared with normal breast tissue. We establish that p53beta can 
bind differentially to promoters and can enhance p53 target gene expression in a promoter-
dependent manner, while Delta133p53 is dominant-negative toward full-length p53, 
inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human 
tumors may explain the difficulties in linking p53 status to the biological properties and drug 
sensitivity of human cancer.", "author" : [ { "dropping-particle" : "", "family" : "Bourdon", 
"given" : "Jean Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Fernandes", "given" : "Kenneth", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Murray-Zmijewski", "given" : "Fiona", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Liu", "given" : "Geng", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Diot", 
"given" : "Alexandra", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Xirodimas", "given" : "Dimitris P.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Saville", "given" : "Mark K.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Lane", "given" : "David P.", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" } ], "container-title" : "Genes and Development", "id" : 
"ITEM-1", "issue" : "18", "issued" : { "date-parts" : [ [ "2005" ] ] }, "page" : "2122-2137", 
"title" : "p53 isoforms can regulate p53 transcriptional activity", "type" : "article-journal", 
"volume" : "19" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=87bfab4c-0377-
4811-b35f-c1e089298fe3" ] } ], "mendeley" : { "formattedCitation" : "(34)", 
"plainTextFormattedCitation" : "(34)", "previouslyFormattedCitation" : "(34)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} and in 2010 by Marcel et al. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1016/j.febslet.2010.10.005", "ISBN" : "1873-3468 (Electronic)\\r0014-5793 (Linking)", 
"ISSN" : "00145793", "PMID" : "20937277", "abstract" : "p53 gene expresses several protein 
isoforms modulating p53-mediated responses through regulation of gene expression. Here, 
we identify a novel p53 isoform, \u0394160p53, lacking the first 159 residues. By 
knockdown experiments and site-directed mutagenesis, we show that \u0394160p53 is 
encoded by \u0394133p53 transcript using ATG160 as translational initiation site. This 
hypothesis is supported by endogenous expression of \u0394160p53 in U2OS, T47D and 
K562 cells, the latter ones carrying a premature stop codon that impairs p53 and 
\u0394133p53 protein expression but not the one of \u0394160p53. Overall, these results 
show that the \u0394133p53 transcript generates two different p53 isoforms, 
\u0394133p53 and \u0394160p53. \u00a9 2010 Federation of European Biochemical 
Societies.", "author" : [ { "dropping-particle" : "", "family" : "Marcel", "given" : "Virginie", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Perrier", "given" : "St\u00e9phane", "non-dropping-particle" : "", "parse-names" 
: false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Aoubala", "given" : "Mustapha", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Ageorges", "given" : "Sylvain", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Groves", "given" : "Michael J.", "non-
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dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Diot", "given" : "Alexandra", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Fernandes", "given" : "Kenneth", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Tauro", "given" : "Sudhir", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", "given" : "Jean Christophe", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "FEBS 
Letters", "id" : "ITEM-1", "issue" : "21", "issued" : { "date-parts" : [ [ "2010" ] ] }, "page" : 
"4463-4468", "title" : "\u0394160p53 is a novel N-terminal p53 isoform encoded by 
\u0394133p53 transcript", "type" : "article-journal", "volume" : "584" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=25cb923a-cb50-419c-b1af-dbe54c5e2949" ] 
} ], "mendeley" : { "formattedCitation" : "(35)", "plainTextFormattedCitation" : "(35)", 
"previouslyFormattedCitation" : "(35)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}. These 
encompassed the full length p53 protein (p53; canonical p53), p53i9 (p53) as reported by 
Flaman et al {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"ISBN" : "0950-9232 (Print)", "ISSN" : "0950-9232 (Print)", "PMID" : "8632903", "abstract" : 
"Alternative splicing affecting the p53 carboxy-terminus has previously been described in 
mouse but not in normal human cells. We report here the detection in normal human 
lymphocytes of an alternatively spliced form of human p53 mRNA containing an additional 
133 bp exon derived from intron 9. This splice variant encodes a truncated protein of 341 
amino-acids including 10 new amino-acids derived from the novel exon. The truncated 
protein, which lacks part of the p53 tetramerization domain, fails to bind DNA in vitro and 
has a transcriptional defect in vivo in both yeast and mammalian cells. Quantitative RT-PCR 
experiments suggest that the alternatively spliced form is only present in significant 
amounts in quiescent cells. Considering the numerous functions ascribed to the carboxy-
terminus of the p53 protein, this splice variant may have important implications for the 
biological role of p53 in normal cells.", "author" : [ { "dropping-particle" : "", "family" : 
"Flaman", "given" : "J M", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Waridel", "given" : "F", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Estreicher", "given" 
: "A", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" 
: "", "family" : "Vannier", "given" : "A", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Limacher", "given" : "J M", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Gilbert", "given" : "D", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Iggo", "given" : "R", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Frebourg", "given" : "T", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Oncogene", "id" : "ITEM-1", "issue" : "4", "issued" : { "date-parts" : [ [ "1996" ] ] }, "page" : 
"813-818", "title" : "The human tumour suppressor gene p53 is alternatively spliced in 
normal cells.", "type" : "article-journal", "volume" : "12" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=381937c4-bbcb-4fbc-8bd9-97637000add4" 
] } ], "mendeley" : { "formattedCitation" : "(36)", "plainTextFormattedCitation" : "(36)", 
"previouslyFormattedCitation" : "(36)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}, and 
40p53 {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
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"10.1038/sj.onc.1205874", "ISBN" : "0950-9232 (Print)\\n0950-9232 (Linking)", "ISSN" : 
"0950-9232", "PMID" : "12360399", "abstract" : "The tumor suppressor protein p53 is 
ubiquitously expressed as a major isoform of 53 kD, but several forms of lower molecular 
weight have been observed. Here, we describe a new isoform, DeltaN-p53, produced by 
internal initiation of translation at codon 40 and lacking the N-terminal first transactivation 
domain. This isoform has impaired transcriptional activation capacity, and does not complex 
with the p53 regulatory protein Mdm2. Furthermore, DeltaN-p53 oligomerizes with full-
length p53 (FL-p53) and negatively regulates its transcriptional and growth-suppressive 
activities. Consistent with the lack of Mdm2 binding, DeltaN-p53 does not accumulate in 
response to DNA-damage, suggesting that this isoform is not involved in the response to 
genotoxic stress. However, in serum-starved cells expressing wild-type p53, DeltaN-p53 
becomes the predominant p53 form during the synchronous progression into S phase after 
serum stimulation. These results suggest that DeltaN-p53 may play a role as a transient, 
negative regulator of p53 during cell cycle progression.", "author" : [ { "dropping-particle" : 
"", "family" : "Courtois", "given" : "St\u00e9phanie", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Verhaegh", "given" : 
"Gerald", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "North", "given" : "Sophie", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Luciani", "given" : "Maria-
Gloria", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Lassus", "given" : "Patrice", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Hibner", "given" : "Ula", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Oren", "given" : "Moshe", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Hainaut", "given" : "Pierre", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Oncogene", 
"id" : "ITEM-1", "issue" : "44", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : "6722-6728", 
"title" : "\u0394N-p53, a natural isoform of p53 lacking the first transactivation domain, 
counteracts growth suppression by wild-type p53", "type" : "article-journal", "volume" : 
"21" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=c9cf92e6-91bc-4ae8-9662-
6d1c61a82804" ] } ], "mendeley" : { "formattedCitation" : "(37)", 
"plainTextFormattedCitation" : "(37)", "previouslyFormattedCitation" : "(37)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. To date, the 12 isoforms expressed are 
classified as follows [Figure 3A; Figure 3B, Figure 3C]:  
 
 p53 
 p53 
 p53 
 
 40p53 
 40p53 
 40p53 
 
 133p53 
 133p53 
 133p53 
 
 160p53 
 160p53 
 160p53 
 
 
2.1 p53, p53 and p53 
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The p53isoform refers to the canonical p53 protein (also named FLp53). It was discovered 
in 1979, as a protein associating with the T antigen from the SV40 virus. (52,53).  It is 
transcribed from P1 (proximal promoter 1) and translated from the canonically spliced 
mRNA transcript (i) using the ATG1 as translation initiation site. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : 
"2514458412", "ISSN" : "08909369", "PMID" : "16131611", "abstract" : "The recently 
discovered p53-related genes, p73 and p63, express multiple splice variants and N-
terminally truncated forms initiated from an alternative promoter in intron 3. To date, no 
alternative promoter and multiple splice variants have been described for the p53 gene. In 
this study, we show that p53 has a gene structure similar to the p73 and p63 genes. The 
human p53 gene contains an alternative promoter and transcribes multiple splice variants. 
We show that p53 variants are expressed in normal human tissue in a tissue-dependent 
manner. We determine that the alternative promoter is conserved through evolution from 
Drosophila to man, suggesting that the p53 family gene structure plays an essential role in 
the multiple activities of the p53 family members. Consistent with this hypothesis, p53 
variants are differentially expressed in human breast tumors compared with normal breast 
tissue. We establish that p53beta can bind differentially to promoters and can enhance p53 
target gene expression in a promoter-dependent manner, while Delta133p53 is dominant-
negative toward full-length p53, inhibiting p53-mediated apoptosis. The differential 
expression of the p53 isoforms in human tumors may explain the difficulties in linking p53 
status to the biological properties and drug sensitivity of human cancer.", "author" : [ { 
"dropping-particle" : "", "family" : "Bourdon", "given" : "Jean Christophe", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Fernandes", "given" : "Kenneth", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Murray-Zmijewski", "given" : "Fiona", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Liu", "given" : "Geng", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Diot", "given" : "Alexandra", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Xirodimas", "given" : "Dimitris P.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Saville", "given" : "Mark K.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Lane", "given" : "David P.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" } ], "container-title" : "Genes and Development", "id" : "ITEM-1", "issue" : "18", 
"issued" : { "date-parts" : [ [ "2005" ] ] }, "page" : "2122-2137", "title" : "p53 isoforms can 
regulate p53 transcriptional activity", "type" : "article-journal", "volume" : "19" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=87bfab4c-0377-4811-b35f-c1e089298fe3" ] 
}, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1177/1947601911408893", "ISBN" : "1947-
6027 (Electronic)\\r1947-6019 (Linking)", "ISSN" : "1947-6019", "PMID" : "21779513", 
"abstract" : "Normal function of the p53 pathway is ubiquitously lost in cancers either 
through mutation or inactivating interaction with viral or cellular proteins. However, it is 
difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
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types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
manner. In this review, we summarize our current knowledge about the biological activities 
of p53 isoforms and propose a molecular mechanism conciliating our current knowledge on 
p53 and integrating p63 and p73 isoforms in the p53 pathway.", "author" : [ { "dropping-
particle" : "", "family" : "Khoury", "given" : "M. P.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", "given" : "J.-C.", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Genes 
& Cancer", "id" : "ITEM-2", "issue" : "4", "issued" : { "date-parts" : [ [ "2011" ] ] }, "page" : 
"453-465", "title" : "p53 Isoforms: An Intracellular Microprocessor?", "type" : "article-
journal", "volume" : "2" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=9d530c4a-b7e0-4241-a1b4-7a5bc16f78ad" 
] } ], "mendeley" : { "formattedCitation" : "(1,34)", "plainTextFormattedCitation" : "(1,34)", 
"previouslyFormattedCitation" : "(1,34)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}  
 
p53 was initially described as p53i9 {ADDIN CSL_CITATION { "citationItems" : [ { "id" : 
"ITEM-1", "itemData" : { "ISBN" : "0950-9232 (Print)", "ISSN" : "0950-9232 (Print)", "PMID" : 
"8632903", "abstract" : "Alternative splicing affecting the p53 carboxy-terminus has 
previously been described in mouse but not in normal human cells. We report here the 
detection in normal human lymphocytes of an alternatively spliced form of human p53 
mRNA containing an additional 133 bp exon derived from intron 9. This splice variant 
encodes a truncated protein of 341 amino-acids including 10 new amino-acids derived from 
the novel exon. The truncated protein, which lacks part of the p53 tetramerization domain, 
fails to bind DNA in vitro and has a transcriptional defect in vivo in both yeast and 
mammalian cells. Quantitative RT-PCR experiments suggest that the alternatively spliced 
form is only present in significant amounts in quiescent cells. Considering the numerous 
functions ascribed to the carboxy-terminus of the p53 protein, this splice variant may have 
important implications for the biological role of p53 in normal cells.", "author" : [ { 
"dropping-particle" : "", "family" : "Flaman", "given" : "J M", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Waridel", "given" : 
"F", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : 
"", "family" : "Estreicher", "given" : "A", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Vannier", "given" : "A", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Limacher", "given" : "J M", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, 
{ "dropping-particle" : "", "family" : "Gilbert", "given" : "D", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Iggo", "given" : "R", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Frebourg", "given" : "T", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" } ], "container-title" : "Oncogene", "id" : "ITEM-1", "issue" : "4", "issued" : { 
"date-parts" : [ [ "1996" ] ] }, "page" : "813-818", "title" : "The human tumour suppressor 
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gene p53 is alternatively spliced in normal cells.", "type" : "article-journal", "volume" : "12" 
}, "uris" : [ "http://www.mendeley.com/documents/?uuid=381937c4-bbcb-4fbc-8bd9-
97637000add4" ] } ], "mendeley" : { "formattedCitation" : "(36)", 
"plainTextFormattedCitation" : "(36)", "previouslyFormattedCitation" : "(36)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. It is produced through the alternative 
splicing of exon 9b (contained within intron 9) which contains a stop codon, resulting in 
mRNA transcript (ii). Translation of mRNA transcript (ii) results in a protein devoid of the 
canonical tetramerization domain and the  - domain; but ending with 10 different amino 
acids –DQTSFQKENC. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", 
"PMID" : "16131611", "abstract" : "The recently discovered p53-related genes, p73 and p63, 
express multiple splice variants and N-terminally truncated forms initiated from an 
alternative promoter in intron 3. To date, no alternative promoter and multiple splice 
variants have been described for the p53 gene. In this study, we show that p53 has a gene 
structure similar to the p73 and p63 genes. The human p53 gene contains an alternative 
promoter and transcribes multiple splice variants. We show that p53 variants are expressed 
in normal human tissue in a tissue-dependent manner. We determine that the alternative 
promoter is conserved through evolution from Drosophila to man, suggesting that the p53 
family gene structure plays an essential role in the multiple activities of the p53 family 
members. Consistent with this hypothesis, p53 variants are differentially expressed in 
human breast tumors compared with normal breast tissue. We establish that p53beta can 
bind differentially to promoters and can enhance p53 target gene expression in a promoter-
dependent manner, while Delta133p53 is dominant-negative toward full-length p53, 
inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human 
tumors may explain the difficulties in linking p53 status to the biological properties and drug 
sensitivity of human cancer.", "author" : [ { "dropping-particle" : "", "family" : "Bourdon", 
"given" : "Jean Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Fernandes", "given" : "Kenneth", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Murray-Zmijewski", "given" : "Fiona", "non-dropping-particle" : "", "parse-names" : false, 
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translation, and alternative promoter usage. p53 isoform proteins thus contain distinct 
protein domains. They are expressed in normal human tissues but are abnormally expressed 
in a wide range of cancer types. We have recently reported that p53 isoform expression is 
associated with breast cancer prognosis, suggesting that they play a role in carcinogenesis. 
Indeed, the cellular response to damages can be switched from cell cycle arrest to apoptosis 
by only manipulating p53 isoform expression. This may provide an explanation to the 
hitherto inconsistent relationship between p53 mutation, treatment response, and outcome 
in breast cancer. However, the molecular mechanism is still unknown. Recent reports 
suggest that it involves modulation of gene expression in a p53-dependent and -
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p53 is similarly devoid of the canonical tetramerization domain and the  - domain, ending 
instead with 15 additional 5 amino acids – MLLDLRWCYFLINSS. This is achieved through a 
different, alternative splicing of intron 9 - exon 9 (contained within intron 9), generating 
mRNA transcript (iii), as well as being transcribed from P1 (proximal promoter 1). 
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p63 genes. The human p53 gene contains an alternative promoter and transcribes multiple 
splice variants. We show that p53 variants are expressed in normal human tissue in a tissue-
dependent manner. We determine that the alternative promoter is conserved through 
evolution from Drosophila to man, suggesting that the p53 family gene structure plays an 
essential role in the multiple activities of the p53 family members. Consistent with this 
hypothesis, p53 variants are differentially expressed in human breast tumors compared with 
normal breast tissue. We establish that p53beta can bind differentially to promoters and 
can enhance p53 target gene expression in a promoter-dependent manner, while 
Delta133p53 is dominant-negative toward full-length p53, inhibiting p53-mediated 
apoptosis. The differential expression of the p53 isoforms in human tumors may explain the 
difficulties in linking p53 status to the biological properties and drug sensitivity of human 
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Exons 9 and 9 are both referred to as “cryptic exons” due to their presence within intron 
9. Both contain stop codons, resulting in exons 10 and 11 being non-coding in  and  mRNA 
variants of p53. This explains why p53 is said to have 11 “canonical” exons and 13 functional 
exons in total. All the above mRNA variants are transcribed from P1 (proximal promoter 1). 
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promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
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types. We have recently reported that p53 isoform expression is associated with breast 
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2.2 40p53, 40p53, 40p53 
 
The 40p53 isoforms are produced by three distinct mechanisms;  by initiation of  
translation at codon 40, by alternative splicing (retention) of intron 2, which contains 
several stop codons or by proteolytic cleavage (54). This results in proteins lacking the first 
39 amino acids which are thus devoid of the first transactivation domain (TAD1). {ADDIN 
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40p53 (also termed p47 or Np53) retains the second transactivation domain; the rest of 
the transcript mirrors p53. The isoform yields not only from the translation of the fourth 
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mRNA transcript (iv), but also from mRNA transcript (i) due to the occurrence of an internal 
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the translation of p53 isoforms", "type" : "article-journal", "volume" : "7" }, "uris" : [ 
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"ISSN" : "08909369", "PMID" : "16131611", "abstract" : "The recently discovered p53-
related genes, p73 and p63, express multiple splice variants and N-terminally truncated 
forms initiated from an alternative promoter in intron 3. To date, no alternative promoter 
and multiple splice variants have been described for the p53 gene. In this study, we show 
that p53 has a gene structure similar to the p73 and p63 genes. The human p53 gene 
contains an alternative promoter and transcribes multiple splice variants. We show that p53 
variants are expressed in normal human tissue in a tissue-dependent manner. We 
determine that the alternative promoter is conserved through evolution from Drosophila to 
man, suggesting that the p53 family gene structure plays an essential role in the multiple 
activities of the p53 family members. Consistent with this hypothesis, p53 variants are 
differentially expressed in human breast tumors compared with normal breast tissue. We 
establish that p53beta can bind differentially to promoters and can enhance p53 target 
gene expression in a promoter-dependent manner, while Delta133p53 is dominant-negative 
toward full-length p53, inhibiting p53-mediated apoptosis. The differential expression of the 
p53 isoforms in human tumors may explain the difficulties in linking p53 status to the 
biological properties and drug sensitivity of human cancer.", "author" : [ { "dropping-
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"page" : "2122-2137", "title" : "p53 isoforms can regulate p53 transcriptional activity", 
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"abstract" : "Normal function of the p53 pathway is ubiquitously lost in cancers either 
through mutation or inactivating interaction with viral or cellular proteins. However, it is 
difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
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promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
manner. In this review, we summarize our current knowledge about the biological activities 
of p53 isoforms and propose a molecular mechanism conciliating our current knowledge on 
p53 and integrating p63 and p73 isoforms in the p53 pathway.", "author" : [ { "dropping-
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Likewise, 40p53 is also clipped of the first 40 amino acids; however, being a  isoform it 
lacks the canonical tetramerization domain and the  - domain as well; instead concluding 
with 10 amino acids – DQTSFQKENC. This is due to the presence of exon 9. This results in 
the transcription of 40p53 from mRNA transcript (v), but similar to the 40p53 isoform, 
an IRES also allows the translation of 40p53 from mRNA transcript (ii). {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1038/sj.embor.7400623", "ISBN" : "1469-221X (Print)\\r1469-221X (Linking)", "ISSN" : 
"1469-221X", "PMID" : "16440000", "abstract" : "The p53 tumour suppressor protein has a 
crucial role in cell\u2010cycle arrest and apoptosis. Previous reports show that the p53 
messenger RNA is translated to produce an amino\u2010terminal\u2010deleted isoform 
(\u0394N\u2010p53) from an internal initiation codon, which acts as a 
dominant\u2010negative inhibitor of full\u2010length p53. Here, we show that two internal 
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ribosome entry sites (IRESs) mediate the translation of both full\u2010length and 
\u0394N\u2010p53 isoforms. The IRES directing the translation of full\u2010length p53 is in 
the 5\u2032\u2010untranslated region of the mRNA, whereas the IRES mediating the 
translation of \u0394N\u2010p53 extends into the protein\u2010coding region. The two 
IRESs show distinct cell\u2010cycle phase\u2010dependent activity, with the IRES for 
full\u2010length p53 being active at the G2\u2013M transition and the IRES for 
\u0394N\u2010p53 showing highest activity at the G1\u2013S transition. These results 
indicate a novel translational control of p53 gene expression and activity.", "author" : [ { 
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related genes, p73 and p63, express multiple splice variants and N-terminally truncated 
forms initiated from an alternative promoter in intron 3. To date, no alternative promoter 
and multiple splice variants have been described for the p53 gene. In this study, we show 
that p53 has a gene structure similar to the p73 and p63 genes. The human p53 gene 
contains an alternative promoter and transcribes multiple splice variants. We show that p53 
variants are expressed in normal human tissue in a tissue-dependent manner. We 
determine that the alternative promoter is conserved through evolution from Drosophila to 
man, suggesting that the p53 family gene structure plays an essential role in the multiple 
activities of the p53 family members. Consistent with this hypothesis, p53 variants are 
differentially expressed in human breast tumors compared with normal breast tissue. We 
establish that p53beta can bind differentially to promoters and can enhance p53 target 
gene expression in a promoter-dependent manner, while Delta133p53 is dominant-negative 
toward full-length p53, inhibiting p53-mediated apoptosis. The differential expression of the 
p53 isoforms in human tumors may explain the difficulties in linking p53 status to the 
biological properties and drug sensitivity of human cancer.", "author" : [ { "dropping-
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difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
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that it involves modulation of gene expression in a p53-dependent and -independent 
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40p53 lacks the first 40 amino acids and as a  isoform (devoid of the canonical 
tetramerization and  domain) it ends with an additional 15 amino acids - MLLDLR 
WCYFLINSS. Again, this is attributed to the alternative splicing of exon 9. It can be 
translated from a sixth mRNA transcript (xi), in the same token as the other 40p53 
isoforms, from mRNA transcript (iii) due to the presence of an IRES. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1038/sj.embor.7400623", 
"ISBN" : "1469-221X (Print)\\r1469-221X (Linking)", "ISSN" : "1469-221X", "PMID" : 
"16440000", "abstract" : "The p53 tumour suppressor protein has a crucial role in 
cell\u2010cycle arrest and apoptosis. Previous reports show that the p53 messenger RNA is 
translated to produce an amino\u2010terminal\u2010deleted isoform (\u0394N\u2010p53) 
from an internal initiation codon, which acts as a dominant\u2010negative inhibitor of 
full\u2010length p53. Here, we show that two internal ribosome entry sites (IRESs) mediate 
the translation of both full\u2010length and \u0394N\u2010p53 isoforms. The IRES 
directing the translation of full\u2010length p53 is in the 5\u2032\u2010untranslated 
region of the mRNA, whereas the IRES mediating the translation of \u0394N\u2010p53 
extends into the protein\u2010coding region. The two IRESs show distinct cell\u2010cycle 
phase\u2010dependent activity, with the IRES for full\u2010length p53 being active at the 
G2\u2013M transition and the IRES for \u0394N\u2010p53 showing highest activity at the 
G1\u2013S transition. These results indicate a novel translational control of p53 gene 
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2.3 133p53, 133p53, 133p53  
 
Within intron-4 lies an internal promoter; named here as P2. Whilst the p53 and 40p53 
isoforms are attributable to P1, the 133p53 isoforms are named so due to the initiation of 
translation at the 133rd amino acid – as a result of P2. Notably, in response to stress, FLp53 
binds and transactivates the internal promoter, thus regulating the expression of its own 
isoforms. In addition to p53, at least four p63/p73 isoforms regulate 133p53’s 
transcription. (57) 
 
As indicated above the 133p53 isoforms are devoid of the first 132 amino acids and thus 
lack the canonical transactivation domain (TA), the proline domain (PRD) and part of the 
DNA – binding domain (DBD). {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", 
"PMID" : "16131611", "abstract" : "The recently discovered p53-related genes, p73 and p63, 
express multiple splice variants and N-terminally truncated forms initiated from an 
alternative promoter in intron 3. To date, no alternative promoter and multiple splice 
variants have been described for the p53 gene. In this study, we show that p53 has a gene 
structure similar to the p73 and p63 genes. The human p53 gene contains an alternative 
promoter and transcribes multiple splice variants. We show that p53 variants are expressed 
in normal human tissue in a tissue-dependent manner. We determine that the alternative 
promoter is conserved through evolution from Drosophila to man, suggesting that the p53 
family gene structure plays an essential role in the multiple activities of the p53 family 
members. Consistent with this hypothesis, p53 variants are differentially expressed in 
human breast tumors compared with normal breast tissue. We establish that p53beta can 
bind differentially to promoters and can enhance p53 target gene expression in a promoter-
dependent manner, while Delta133p53 is dominant-negative toward full-length p53, 
inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human 
tumors may explain the difficulties in linking p53 status to the biological properties and drug 
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but 12 different p53 proteins (isoforms) due to alternative splicing, alternative initiation of 
translation, and alternative promoter usage. p53 isoform proteins thus contain distinct 
protein domains. They are expressed in normal human tissues but are abnormally expressed 
in a wide range of cancer types. We have recently reported that p53 isoform expression is 
associated with breast cancer prognosis, suggesting that they play a role in carcinogenesis. 
Indeed, the cellular response to damages can be switched from cell cycle arrest to apoptosis 
by only manipulating p53 isoform expression. This may provide an explanation to the 
hitherto inconsistent relationship between p53 mutation, treatment response, and outcome 
in breast cancer. However, the molecular mechanism is still unknown. Recent reports 
suggest that it involves modulation of gene expression in a p53-dependent and -
independent manner. In this review, we summarize our current knowledge about the 
biological activities of p53 isoforms and propose a molecular mechanism conciliating our 
current knowledge on p53 and integrating p63 and p73 isoforms in the p53 pathway.", 
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Expanding upon the previous arrangement, 133p53 will thus lack the transactivation 
domain, the proline domain and part of the DNA – binding domain and being an  isoform 
the rest mirrors FLp53. It is translated from mRNA transcript (vii). {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : 
"2514458412", "ISSN" : "08909369", "PMID" : "16131611", "abstract" : "The recently 
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reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
 {PAGE  } 
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133p53 due to the presence of exon 9 and being translated from P2, will lack the TA 
domain, PRD, DBD, the canonical tetramerization domain and the  - domain instead 
concluding with 10 amino acids – DQTSFQKENC. It is translated from the eighth mRNA 
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"16131611", "abstract" : "The recently discovered p53-related genes, p73 and p63, express 
multiple splice variants and N-terminally truncated forms initiated from an alternative 
promoter in intron 3. To date, no alternative promoter and multiple splice variants have 
been described for the p53 gene. In this study, we show that p53 has a gene structure 
similar to the p73 and p63 genes. The human p53 gene contains an alternative promoter 
and transcribes multiple splice variants. We show that p53 variants are expressed in normal 
human tissue in a tissue-dependent manner. We determine that the alternative promoter is 
conserved through evolution from Drosophila to man, suggesting that the p53 family gene 
structure plays an essential role in the multiple activities of the p53 family members. 
Consistent with this hypothesis, p53 variants are differentially expressed in human breast 
tumors compared with normal breast tissue. We establish that p53beta can bind 
differentially to promoters and can enhance p53 target gene expression in a promoter-
dependent manner, while Delta133p53 is dominant-negative toward full-length p53, 
inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human 
tumors may explain the difficulties in linking p53 status to the biological properties and drug 
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Unsurprisingly, 133p53 will lack the TA domain, PRD and DBD being 133p53 isoform, 
and being  isoform is also pared of the canonical tetramerization and the  domain due to 
exon 9. It is translated from the ninth mRNA transcript (ix). {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : 
"2514458412", "ISSN" : "08909369", "PMID" : "16131611", "abstract" : "The recently 
discovered p53-related genes, p73 and p63, express multiple splice variants and N-
terminally truncated forms initiated from an alternative promoter in intron 3. To date, no 
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alternative promoter and multiple splice variants have been described for the p53 gene. In 
this study, we show that p53 has a gene structure similar to the p73 and p63 genes. The 
human p53 gene contains an alternative promoter and transcribes multiple splice variants. 
We show that p53 variants are expressed in normal human tissue in a tissue-dependent 
manner. We determine that the alternative promoter is conserved through evolution from 
Drosophila to man, suggesting that the p53 family gene structure plays an essential role in 
the multiple activities of the p53 family members. Consistent with this hypothesis, p53 
variants are differentially expressed in human breast tumors compared with normal breast 
tissue. We establish that p53beta can bind differentially to promoters and can enhance p53 
target gene expression in a promoter-dependent manner, while Delta133p53 is dominant-
negative toward full-length p53, inhibiting p53-mediated apoptosis. The differential 
expression of the p53 isoforms in human tumors may explain the difficulties in linking p53 
status to the biological properties and drug sensitivity of human cancer.", "author" : [ { 
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difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
manner. In this review, we summarize our current knowledge about the biological activities 
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2.4 160p53, 160p53, 160p53 
 
The 160p53 isoforms are all generated through the alternative initiation of translation at 
ATG 160 of the 133p53 transcripts. These isoforms all lack the first 159 amino acids.  
 
The ,  and  160p53 isoforms all echo the previous isoforms in terms of their C-terminal 
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Figure 3. (A) A schematic of the 9 p53 mRNA transcripts produced in humans, i-ix. Exons are to scale with a 
condensed intron 1. Non-coding exons are blacked out. Features of the mRNA transcripts are included; splicing, 
promoter usage, the presence of an IRES and intron retention. (B) A schematic of the 12 p53 protein isoforms 
produced by the 9 mRNA transcripts; p53, p53, p53, 40p53, 40p53, 40p53, 133p53, 133p53, 
133p53, 160p53, 160p53 and 160p53. Theoretical molecular weight is noted on the right. Promoter 1 is 
responsible for initiation of translation for transcripts i-vi. mRNA i-iii encode for the full-length protein isoforms. 
The retention of intron 2 (i2) in mRNA iv-vi and consequentially several stop codons, leads to initiation of 
translation from codon 40 and thus the production of the 40p53 isoforms. The 40p53 isoforms can also be 
produced by mRNA i-iii via the indicated IRES. The usage of an alternative promoter in intron 4 (promoter 2) is 
used for initiation of translation of mRNA vii-ix, which is utilised for translation of the 133p53 and 160p53 
isoforms. Alternative splicing of intron 9 (colour coded) produces alternative C terminal regions, designated ,  
and . 
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3- Biological Activities of the p53 Isoform 
 
3.1 Normal Tissue Specific Expression of the Isoforms 
 
The p53 mRNA variants are differentially expressed in a tissue dependent manner. {ADDIN 
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dependent manner. We determine that the alternative promoter is conserved through 
evolution from Drosophila to man, suggesting that the p53 family gene structure plays an 
essential role in the multiple activities of the p53 family members. Consistent with this 
hypothesis, p53 variants are differentially expressed in human breast tumors compared with 
normal breast tissue. We establish that p53beta can bind differentially to promoters and 
can enhance p53 target gene expression in a promoter-dependent manner, while 
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}, "uris" : [ "http://www.mendeley.com/documents/?uuid=87bfab4c-0377-4811-b35f-
c1e089298fe3" ] } ], "mendeley" : { "formattedCitation" : "(34)", 
"plainTextFormattedCitation" : "(34)", "previouslyFormattedCitation" : "(34)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}  
p53/40p53 mRNA variants for example, are expressed in most normal tissue but could 
be detected in brain, lung, prostate, muscle, foetal brain, spinal cord and foetal liver.  
Likewise, p53/40p53 does not manifest within lung, spleen, testis, foetal brain, spinal 
cord and foetal liver (but is otherwise found in all other tissue). 
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133/160p53 mRNA variants are expressed in most normal tissue with the exception of 
prostate, uterus, skeletal muscle and breast. 
133/160p53 mRNA on the other hand, are only detectable within the colon, bone 
marrow, testis, foetal brain and intestine.  
133/160p53 are similarly expressed in most normal tissue, with the exception of brain, 
heart, lung, foetal liver, salivary gland, breast and intestine.  
 
3.2 Subcellular Localisation of the protein Isoforms (ectopic expression)   
 
P53 is never expressed as a single protein. Several p53 isoforms are always co-expressed in 
cells. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", "PMID" : "16131611", 
"abstract" : "The recently discovered p53-related genes, p73 and p63, express multiple 
splice variants and N-terminally truncated forms initiated from an alternative promoter in 
intron 3. To date, no alternative promoter and multiple splice variants have been described 
for the p53 gene. In this study, we show that p53 has a gene structure similar to the p73 and 
p63 genes. The human p53 gene contains an alternative promoter and transcribes multiple 
splice variants. We show that p53 variants are expressed in normal human tissue in a tissue-
dependent manner. We determine that the alternative promoter is conserved through 
evolution from Drosophila to man, suggesting that the p53 family gene structure plays an 
essential role in the multiple activities of the p53 family members. Consistent with this 
hypothesis, p53 variants are differentially expressed in human breast tumors compared with 
normal breast tissue. We establish that p53beta can bind differentially to promoters and 
can enhance p53 target gene expression in a promoter-dependent manner, while 
Delta133p53 is dominant-negative toward full-length p53, inhibiting p53-mediated 
apoptosis. The differential expression of the p53 isoforms in human tumors may explain the 
difficulties in linking p53 status to the biological properties and drug sensitivity of human 
cancer.", "author" : [ { "dropping-particle" : "", "family" : "Bourdon", "given" : "Jean 
Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Fernandes", "given" : "Kenneth", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Murray-Zmijewski", 
"given" : "Fiona", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Liu", "given" : "Geng", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Diot", "given" : 
"Alexandra", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Xirodimas", "given" : "Dimitris P.", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Saville", "given" : 
"Mark K.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Lane", "given" : "David P.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" } ], "container-title" : "Genes and Development", "id" : "ITEM-1", 
"issue" : "18", "issued" : { "date-parts" : [ [ "2005" ] ] }, "page" : "2122-2137", "title" : "p53 
isoforms can regulate p53 transcriptional activity", "type" : "article-journal", "volume" : "19" 
}, "uris" : [ "http://www.mendeley.com/documents/?uuid=87bfab4c-0377-4811-b35f-
c1e089298fe3" ] } ], "mendeley" : { "formattedCitation" : "(34)", 
"plainTextFormattedCitation" : "(34)", "previouslyFormattedCitation" : "(34)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}  However, the lack of isoform specific 
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antibodies prevents to study the endogenous subcellular localisation of each p53 isoforms. 
Therefore, the subcellular locations of some p53 protein isoform was first investigated after 
transfection of single p53 isoform cDNA in cells devoid of endogenous p53 expression. Here 
below are the summary of the findings. 
Ectopically expressed Full length p53 (p53) is localised within the nucleus. Ectopic p53 
appears to localise predominantly within the nucleus, but low amounts were also present 
within the cytoplasm. However, p53 was pinpointed within both the nucleus and the 
cytoplasm (a result dependent on the cell type that was tested), suggesting that p53 would 
also shuttle between the nucleus and the cytoplasm.  
133p53 is localised both in the nucleus and cytoplasm. 133p53 is likewise confined 
within both the nucleus and cytoplasm with some speckles staining in some cells. 133p53 
is interesting in that it centralises only within the cytoplasm of a cell; as mentioned 
previously 133p53 and 133p53 differ through the last amino acids (ending with 10 and 
15 respectively), strongly suggesting that the sequence of amino acids located within the C 
terminus of the isoforms can alter their subcellular localisation. (48) 
 
40p53 is noteworthy in that it can alter subcellular localisation of other isoforms. 
Residing within the cytoplasm (whilst p53 is mostly nuclear), the presence of 40p53 
alters the localisation of p53 from the nucleus to the cytoplasm where 40p53 dwells. 
This observation occurs particularly in times of cellular stress. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1128/MCB.24.18.7987-
7997.2004", "ISBN" : "0270-7306", "ISSN" : "0270-7306", "PMID" : "15340061", "abstract" : 
"The development of cancer is a multistep process involving mutations in proto-oncogenes, 
tumor suppressor genes, and other genes which control cell proliferation, telomere stability, 
angiogenesis, and other complex traits. Despite this complexity, the cellular pathways 
controlled by the p53 tumor suppressor protein are compromised in most, if not all, 
cancers. In normal cells, p53 controls cell proliferation, senescence, and/or mediates 
apoptosis in response to stress, cell damage, or ectopic oncogene expression, properties 
which make p53 the prototype tumor suppressor gene. Defining the mechanisms of 
regulation of p53 activity in normal and tumor cells has therefore been a major priority in 
cell biology and cancer research. The present study reveals a novel and potent mechanism 
of p53 regulation originating through alternative splicing of the human p53 gene resulting in 
the expression of a novel p53 mRNA. This novel p53 mRNA encodes an N-terminally deleted 
isoform of p53 termed p47. As demonstrated within, p47 was able to effectively suppress 
p53-mediated transcriptional activity and impair p53-mediated growth suppression. It was 
possible to select for p53-null cells expressing p47 alone or coexpressing p53 in the 
presence of p47 but not cells expressing p53 alone. This showed that p47 itself does not 
suppress cell viability but could control p53-mediated growth suppression. Interestingly, 
p47 was monoubiquitinated in an Mdm2-independent manner, and this was associated with 
its export out of the nucleus. In the presence of p47, there was a reduction in Mdm2-
mediated polyubiquitination and degradation of p53, and this was also associated with 
increased monoubiquitination and nuclear export of p53. The expression of p47 through 
alternative splicing of the p53 gene thus has a major influence over p53 activity at least in 
part through controlling p53 ubiquitination and cell localization.", "author" : [ { "dropping-
particle" : "", "family" : "Ghosh", "given" : "Anirban", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Stewart", "given" : 
"Deborah", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
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particle" : "", "family" : "Matlashewski", "given" : "Greg", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" } ], "container-title" : "Molecular and cellular biology", 
"id" : "ITEM-1", "issue" : "18", "issued" : { "date-parts" : [ [ "2004" ] ] }, "page" : "7987-97", 
"title" : "Regulation of human p53 activity and cell localization by alternative splicing.", 
"type" : "article-journal", "volume" : "24" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=71e0792b-5ecc-4c98-9de8-f3fab0418d45" ] 
} ], "mendeley" : { "formattedCitation" : "(42)", "plainTextFormattedCitation" : "(42)", 
"previouslyFormattedCitation" : "(42)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
40p53 was first discovered as the “little brother” of p53, with its consequences on p53 
being of particular interest. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1038/sj.onc.1205874", "ISBN" : "0950-9232 (Print)\\n0950-9232 
(Linking)", "ISSN" : "0950-9232", "PMID" : "12360399", "abstract" : "The tumor suppressor 
protein p53 is ubiquitously expressed as a major isoform of 53 kD, but several forms of 
lower molecular weight have been observed. Here, we describe a new isoform, DeltaN-p53, 
produced by internal initiation of translation at codon 40 and lacking the N-terminal first 
transactivation domain. This isoform has impaired transcriptional activation capacity, and 
does not complex with the p53 regulatory protein Mdm2. Furthermore, DeltaN-p53 
oligomerizes with full-length p53 (FL-p53) and negatively regulates its transcriptional and 
growth-suppressive activities. Consistent with the lack of Mdm2 binding, DeltaN-p53 does 
not accumulate in response to DNA-damage, suggesting that this isoform is not involved in 
the response to genotoxic stress. However, in serum-starved cells expressing wild-type p53, 
DeltaN-p53 becomes the predominant p53 form during the synchronous progression into S 
phase after serum stimulation. These results suggest that DeltaN-p53 may play a role as a 
transient, negative regulator of p53 during cell cycle progression.", "author" : [ { "dropping-
particle" : "", "family" : "Courtois", "given" : "St\u00e9phanie", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Verhaegh", "given" 
: "Gerald", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "North", "given" : "Sophie", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Luciani", "given" : "Maria-
Gloria", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Lassus", "given" : "Patrice", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Hibner", "given" : "Ula", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Oren", "given" : "Moshe", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Hainaut", "given" : "Pierre", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Oncogene", 
"id" : "ITEM-1", "issue" : "44", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : "6722-8", 
"title" : "DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, 
counteracts growth suppression by wild-type p53.", "type" : "article-journal", "volume" : 
"21" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=1e218c4f-6825-422c-a440-
21b1d83a4b3a" ] }, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1038/ncb801", "ISBN" : 
"1465-7392 (Print)\\r1465-7392 (Linking)", "ISSN" : "1465-7392", "PMID" : "12032546", 
"abstract" : "Activation of the p53 tumour suppressor protein can lead to cell-cycle arrest or 
apoptosis. p53 function is controlled by the mdm2 oncogene product, which targets p53 for 
proteasomal degradation. In this report we demonstrate that Mdm2 induces translation of 
the p53 mRNA from two alternative initiation sites, giving full-length p53 and another 
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protein with a relative molecular mass (M(r)) of approximately 47K; we designate this 
protein as p53/47. This translation induction requires Mdm2 to interact directly with the 
nascent p53 polypeptide. The alternatively translated p53/47 does not contain the Mdm2-
binding site and it lacks the most amino-terminal transcriptional-activation domain of p53. 
Increased expression of p53/47 stabilizes p53 in the presence of Mdm2, and alters the 
expression levels of p53-induced gene products. These results show how the interaction of 
Mdm2 with p53 leads to a change in the ratio of full-length p53 to p53/47 by inducing 
translation of both p53 proteins and the subsequent selective degradation of full-length 
p53. Thus, Mdm2 controls the expression levels of p53 through a dual mechanism that 
involves induction of synthesis and targeting for degradation.", "author" : [ { "dropping-
particle" : "", "family" : "Yin", "given" : "Yili", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Stephen", "given" : "C W", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Luciani", "given" : "M Gloria", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "F\u00e5hraeus", "given" : "Robin", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Nature cell 
biology", "id" : "ITEM-2", "issue" : "6", "issued" : { "date-parts" : [ [ "2002" ] ] }, "page" : 
"462-7", "title" : "p53 Stability and activity is regulated by Mdm2-mediated induction of 
alternative p53 translation products.", "type" : "article-journal", "volume" : "4" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=f4bb2be0-2921-4b66-9fae-06eb7ecbdafa" ] 
} ], "mendeley" : { "formattedCitation" : "(43,44)", "plainTextFormattedCitation" : "(43,44)", 
"previouslyFormattedCitation" : "(43,44)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} Of all 
the isoforms, 40p53 has been the most intensively studied, unveiling many functions 
relevant to our understanding of the isoforms. For example, despite loss of TAD1, the 
presence of the second transactivation domain allows 40p53 to induce expression of 
genes . {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1074/jbc.M005676200", "ISBN" : "0021-9258", "ISSN" : "00219258", "PMID" : 
"10982799", "abstract" : "The p53 protein contains several functional domains necessary for 
inducing cell cycle arrest and apoptosis. The C-terminal basic domain within residues 364-
393 and the proline-rich domain within residues 64-91 are required for apoptotic activity. In 
addition, activation domain 2 within residues 43-63 is necessary for apoptotic activity when 
the N-terminal activation domain 1 within residues 1-42 is deleted (DeltaAD1) or mutated 
(AD1(-)). Here we have discovered that an activation domain 2 mutation at residues 53-54 
(AD2(-)) abrogates the apoptotic activity but has no significant effect on cell cycle arrest. We 
have also found that p53-(DeltaAD2), which lacks activation domain 2, is inert in inducing 
apoptosis. p53-(AD2(-)DeltaBD), which is defective in activation domain 2 and lacks the C-
terminal basic domain, p53-(DeltaAD2DeltaBD), which lacks both activation domain 2 and 
the C-terminal basic domain, and p53-(DeltaPRDDeltaBD), which lacks both the proline-rich 
domain and the C-terminal basic domain, are also inert in inducing apoptosis. All four 
mutants are still capable of inducing cell cycle arrest, albeit to a lesser extent than wild-type 
p53. Interestingly, we have found that deletion of the N-terminal activation domain 1 
alleviates the requirement of the C-terminal basic domain for apoptotic activity. Thus, we 
have generated a small but potent p53-(DeltaAD1DeltaBD) molecule. Furthermore, we have 
determined that at least two of the three domains (activation domain 1, activation domain 
2, and the proline-rich domain), are required for inducing cell cycle arrest. Taken together, 
our results suggest that activation domain 2 and the proline-rich domain form an activation 
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domain for inducing pro-apoptotic genes or inhibiting anti-apoptotic genes. The C-terminal 
basic domain is required for maintaining this activation domain competent for 
transactivation or transrepression.", "author" : [ { "dropping-particle" : "", "family" : "Zhu", 
"given" : "Jianhui", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Zhang", "given" : "Shunzhen", "non-dropping-particle" : 
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"title" : "Definition of the p53 functional domains necessary for inducing apoptosis", "type" : 
"article-journal", "volume" : "275" }, "uris" : [ 
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] }, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1074/jbc.273.21.13030", "ISBN" : "0021-9258 
(Print)\\r0021-9258 (Linking)", "ISSN" : "00219258", "PMID" : "9582339", "abstract" : "The 
ability of p53 to induce apoptosis requires its sequence-specific DNA binding activity; 
however, the transactivation-deficient p53(Gln22-Ser23) can still induce apoptosis. 
Previously, we have shown that the region between residues 23 and 97 in p53 is necessary 
for such activity. In an effort to more precisely map a domain necessary for apoptosis within 
the N terminus, we found that deletion of the N-terminal 23 amino acids compromises, but 
does not abolish, p53 induction of apoptosis. Surprisingly, p53(Delta1-42), which lacks the 
N-terminal 42 amino acids and the previously defined activation domain, retains the ability 
to induce apoptosis to an even higher level than wild-type p53. A more extensive deletion, 
which eliminates the N-terminal 63 amino acids, renders p53 completely inert in mediating 
apoptosis. In addition, we found that both p53(Delta1-42) and p53(Gln22-Ser23) can 
activate a subset of cellular p53 targets. Furthermore, we showed that residues 53 and 54 
are critical for the apoptotic and transcriptional activities of both p53(Delta1-42) and 
p53(Gln22-Ser23). Taken together, these data suggest that within residues 43-63 lie an 
apoptotic domain as well as another transcriptional activation domain. We therefore 
postulate that the apoptotic activity in p53(Gln22-Ser23) and p53(Delta1-42) is still 
transcription-dependent.", "author" : [ { "dropping-particle" : "", "family" : "Zhu", "given" : 
"Jianhui", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Zhou", "given" : "Wenjing", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Jiang", "given" : "Jieyuan", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Chen", "given" : "Xinbin", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" } ], "container-title" : "Journal of Biological Chemistry", "id" : "ITEM-2", "issue" : 
"21", "issued" : { "date-parts" : [ [ "1998" ] ] }, "page" : "13030-13036", "title" : 
"Identification of a novel p53 functional domain that is necessary for mediating apoptosis", 
"type" : "article-journal", "volume" : "273" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=dfd2f8f2-e561-4b4f-a0bb-101b5ef7bb78" ] 
} ], "mendeley" : { "formattedCitation" : "(5,6)", "plainTextFormattedCitation" : "(5,6)", 
"previouslyFormattedCitation" : "(5,6)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
40p53 has also been shown to modulate full length p53’s ability to transcribe genes, by 
binding and forming a 40p53/p53 hetero-complex via tetramerization; a concept also 
explaining the location shift p53 shows (from nucleus to cytoplasm) in the presence of 
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40p53. The formation of the 40p53/p53 complex requires a functional 
oligomerization domain. Other notable functions of 40p53 are modulation of FLp53 
breakdown by MDM2 and the obstruction of p53 – induced apoptosis; therefore explaining 
why it was “oversimplified” as being dominant negative towards canonical p53. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1128/MCB.24.18.7987-7997.2004", "ISBN" : "0270-7306", "ISSN" : "0270-7306", "PMID" 
: "15340061", "abstract" : "The development of cancer is a multistep process involving 
mutations in proto-oncogenes, tumor suppressor genes, and other genes which control cell 
proliferation, telomere stability, angiogenesis, and other complex traits. Despite this 
complexity, the cellular pathways controlled by the p53 tumor suppressor protein are 
compromised in most, if not all, cancers. In normal cells, p53 controls cell proliferation, 
senescence, and/or mediates apoptosis in response to stress, cell damage, or ectopic 
oncogene expression, properties which make p53 the prototype tumor suppressor gene. 
Defining the mechanisms of regulation of p53 activity in normal and tumor cells has 
therefore been a major priority in cell biology and cancer research. The present study 
reveals a novel and potent mechanism of p53 regulation originating through alternative 
splicing of the human p53 gene resulting in the expression of a novel p53 mRNA. This novel 
p53 mRNA encodes an N-terminally deleted isoform of p53 termed p47. As demonstrated 
within, p47 was able to effectively suppress p53-mediated transcriptional activity and impair 
p53-mediated growth suppression. It was possible to select for p53-null cells expressing p47 
alone or coexpressing p53 in the presence of p47 but not cells expressing p53 alone. This 
showed that p47 itself does not suppress cell viability but could control p53-mediated 
growth suppression. Interestingly, p47 was monoubiquitinated in an Mdm2-independent 
manner, and this was associated with its export out of the nucleus. In the presence of p47, 
there was a reduction in Mdm2-mediated polyubiquitination and degradation of p53, and 
this was also associated with increased monoubiquitination and nuclear export of p53. The 
expression of p47 through alternative splicing of the p53 gene thus has a major influence 
over p53 activity at least in part through controlling p53 ubiquitination and cell 
localization.", "author" : [ { "dropping-particle" : "", "family" : "Ghosh", "given" : "Anirban", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Stewart", "given" : "Deborah", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Matlashewski", "given" : "Greg", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : 
"Molecular and cellular biology", "id" : "ITEM-1", "issue" : "18", "issued" : { "date-parts" : [ [ 
"2004" ] ] }, "page" : "7987-97", "title" : "Regulation of human p53 activity and cell 
localization by alternative splicing.", "type" : "article-journal", "volume" : "24" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=71e0792b-5ecc-4c98-9de8-f3fab0418d45" ] 
}, { "id" : "ITEM-2", "itemData" : { "DOI" : "10.1038/sj.onc.1205874", "ISBN" : "0950-9232 
(Print)\\n0950-9232 (Linking)", "ISSN" : "0950-9232", "PMID" : "12360399", "abstract" : 
"The tumor suppressor protein p53 is ubiquitously expressed as a major isoform of 53 kD, 
but several forms of lower molecular weight have been observed. Here, we describe a new 
isoform, DeltaN-p53, produced by internal initiation of translation at codon 40 and lacking 
the N-terminal first transactivation domain. This isoform has impaired transcriptional 
activation capacity, and does not complex with the p53 regulatory protein Mdm2. 
Furthermore, DeltaN-p53 oligomerizes with full-length p53 (FL-p53) and negatively 
regulates its transcriptional and growth-suppressive activities. Consistent with the lack of 
Mdm2 binding, DeltaN-p53 does not accumulate in response to DNA-damage, suggesting 
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that this isoform is not involved in the response to genotoxic stress. However, in serum-
starved cells expressing wild-type p53, DeltaN-p53 becomes the predominant p53 form 
during the synchronous progression into S phase after serum stimulation. These results 
suggest that DeltaN-p53 may play a role as a transient, negative regulator of p53 during cell 
cycle progression.", "author" : [ { "dropping-particle" : "", "family" : "Courtois", "given" : 
"St\u00e9phanie", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
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"suffix" : "" } ], "container-title" : "Oncogene", "id" : "ITEM-2", "issue" : "44", "issued" : { 
"date-parts" : [ [ "2002" ] ] }, "page" : "6722-6728", "title" : "\u0394N-p53, a natural isoform 
of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type 
p53", "type" : "article-journal", "volume" : "21" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=c9cf92e6-91bc-4ae8-9662-6d1c61a82804" ] 
} ], "mendeley" : { "formattedCitation" : "(37,42)", "plainTextFormattedCitation" : "(37,42)", 
"previouslyFormattedCitation" : "(37,42)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
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3.3 Apoptosis and Cell Cycle Arrest 
 
Although p53 isoforms are co-expressed at physiological level, the biochemical and 
biological activities were investigated as single agents by ectopic expression in p53-null cells. 
The activity of p53 and 133p53 in inducing apoptosis was investigated by transfection. 
133p53, when transfected in cells devoid of any p53 gene, was found to be inert in 
promoting apoptosis. In animal models, zebrafish 113p53 is homologous to human 
133p53. Depletion of 113p53 by morpholino injection in zebrafish embryos still 
expressing the other p53 isoforms, promotes embryos death in response to sublethal 
ionising radiation, suggesting that 113p53 modulates p53 pro-apoptotic activities and 
favours p53 pro-survival activities. Interestingly, sublethal ionising radiation triggered a p53-
induced 113p53 isoforms expression, suggesting a positive feedback loop in response to 
ionising radiation. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1101/gad.1761609", "ISBN" : "1549-5477", "ISSN" : "08909369", "PMID" : 
"19204115", "abstract" : "p53 is a well-known tumor suppressor and is also involved in 
processes of organismal aging and developmental control. A recent exciting development in 
the p53 field is the discovery of various p53 isoforms. One p53 isoform is human 
Delta133p53 and its zebrafish counterpart Delta113p53. These N-terminal-truncated p53 
isoforms are initiated from an alternative p53 promoter, but their expression regulation and 
physiological significance at the organismal level are not well understood. We show here 
that zebrafish Delta113p53 is directly transactivated by full-length p53 in response to 
developmental and DNA-damaging signals. More importantly, we show that Delta113p53 
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functions to antagonize p53-induced apoptosis via activating bcl2L (closest to human Bcl-
x(L)), and knockdown of Delta113p53 enhances p53-mediated apoptosis under stress 
conditions. Thus, we demonstrate that the p53 genetic locus contains a new p53 response 
gene and that Delta113p53 does not act in a dominant-negative manner toward p53 but 
differentially modulates p53 target gene expression to antagonize p53 apoptotic activity at 
the physiological level in zebrafish. Our results establish a novel feedback pathway that 
modulates the p53 response and suggest that modulation of the p53 pathway by p53 
isoforms might have an impact on p53 tumor suppressor activity.", "author" : [ { "dropping-
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dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Bourdon", "given" : "Jean Christophe", "non-dropping-particle" : "", "parse-
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is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish", 
"type" : "article-journal", "volume" : "23" }, "uris" : [ 
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In human osteosarcoma U2OS cells expressing WT TP53 gene and treated with doxorubicin, 
133p53 expression is induced compared to other p53 isoforms in a p53-dependent 
manner. In response to low-dose of doxorubicin, U2OS cells trigger a p53-mediated cell 
cycle arrest in G2. However, after depletion of 133p53, U2OS cells promotes cell death and 
G1 cell cycle arrest in response to doxorubicin.  Re-introduction of 133p53 restored G2 
cell cycle arrest in response to doxorubicin, while inhibiting p53-mediated apoptosis and G1 
cell cycle arrest. (61) The G2 cell cycle arrest may enable 133p53-mediated DNA repair by 
homologous recombination as recently reported. (62) 
 The data suggest that 133p53 contribute to the p53-mediated cell fate decision in 
response to ionising radiation or doxorubicin treatment. This observation, in the words of 
Aoubala et al, “indicates that Δ133p53α does not exclusively inactivate FLp53.” {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1038/cdd.2010.91", "ISBN" : "1382496400", "ISSN" : "1476-5403", "PMID" : 
"20689555", "abstract" : "We have previously reported that the human p53 gene encodes at 
least nine different p53 isoforms, including \u0394133p53\u03b1, which can modulate p53 
transcriptional activity and apoptosis. In this study, we aimed to investigate the regulation 
of \u0394133p53\u03b1 isoform expression and its physiological role in modulating cell 
cycle arrest and apoptosis. We report here that in response to a low dose of doxorubicin 
(which induces cell cycle arrest without promoting apoptosis), p53 directly transactivates 
the human p53 internal promoter, inducing \u0394133p53\u03b1 protein expression. The 
induced \u0394133p53\u03b1 then inhibits p53-dependent apoptosis and G1 arrest 
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without inhibiting p53-dependent G2 arrest. Therefore, endogenous \u0394133p53\u03b1 
does not exclusively function in a dominant-negative manner toward p53, but differentially 
regulates cell cycle arrest and apoptosis.", "author" : [ { "dropping-particle" : "", "family" : 
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"S", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : 
"", "family" : "Bernard", "given" : "H", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Prats", "given" : "A-C", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Lane", 
"given" : "D P", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Bourdon", "given" : "J-C", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" } ], "container-title" : "Cell death and differentiation", "id" 
: "ITEM-1", "issue" : "2", "issued" : { "date-parts" : [ [ "2011" ] ] }, "page" : "248-58", "title" : 
"p53 directly transactivates \u0394133p53\u03b1, regulating cell fate outcome in response 
to DNA damage.", "type" : "article-journal", "volume" : "18" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=72caef41-561b-46ed-a12b-928cb5767416" 
] } ], "mendeley" : { "formattedCitation" : "(46)", "plainTextFormattedCitation" : "(46)", 
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3.4 Cellular Senescence 
 
Following in a similar vein, the isoforms (p53 and 133p53) were investigated for their 
function in cellular senescence. It was noted that when cells underwent senescence, the 
levels of p53 was elevated to the point of being detectable, whilst the protein level of 
133p53 was distinctly lower. It was also proven that amplified levels of 133p53 
thwarted cellular senescence and promoted proliferative activity by repressing p21 and 
miR34 expression. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1038/ncb1928", "ISBN" : "1465-7392", "ISSN" : "1476-4679", "PMID" : 
"19701195", "abstract" : "The finite proliferative potential of normal human cells leads to 
replicative cellular senescence, which is a critical barrier to tumour progression in vivo. We 
show that the human p53 isoforms Delta133p53 and p53beta function in an endogenous 
regulatory mechanism for p53-mediated replicative senescence. Induced p53beta and 
diminished Delta133p53 were associated with replicative senescence, but not oncogene-
induced senescence, in normal human fibroblasts. The replicatively senescent fibroblasts 
also expressed increased levels of miR-34a, a p53-induced microRNA, the antisense 
inhibition of which delayed the onset of replicative senescence. The siRNA (short interfering 
RNA)-mediated knockdown of endogenous Delta133p53 induced cellular senescence, which 
was attributed to the regulation of p21(WAF1) and other p53 transcriptional target genes. In 
overexpression experiments, whereas p53beta cooperated with full-length p53 to 
accelerate cellular senescence, Delta133p53 repressed miR-34a expression and extended 
the cellular replicative lifespan, providing a functional connection of this microRNA to the 
p53 isoform-mediated regulation of senescence. The senescence-associated signature of 
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p53 isoform expression (that is, elevated p53beta and reduced Delta133p53) was observed 
in vivo in colon adenomas with senescent phenotypes. The increased Delta133p53 and 
decreased p53beta isoform expression found in colon carcinoma may signal an escape from 
the senescence barrier during the progression from adenoma to carcinoma.", "author" : [ { 
"dropping-particle" : "", "family" : "Fujita", "given" : "Kaori", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Mondal", "given" : 
"Abdul M", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Horikawa", "given" : "Izumi", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Nguyen", "given" : "Giang 
H", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : 
"", "family" : "Kumamoto", "given" : "Kensuke", "non-dropping-particle" : "", "parse-names" 
: false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Sohn", "given" : "Jane J", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Bowman", "given" : "Elise D", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Mathe", "given" : "Ewy A", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Schetter", "given" : "Aaron J", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Pine", "given" : "Sharon R", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Ji", "given" : "Helen", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
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"Bourdon", "given" : "Jean-Christophe", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Lane", "given" : "David P", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Harris", "given" : "Curtis C", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
} ], "container-title" : "Nature cell biology", "id" : "ITEM-1", "issue" : "9", "issued" : { "date-
parts" : [ [ "2009" ] ] }, "page" : "1135-42", "title" : "p53 isoforms Delta133p53 and p53beta 
are endogenous regulators of replicative cellular senescence.", "type" : "article-journal", 
"volume" : "11" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=5d4c66ac-e9a1-
43c0-bf52-f17f72757143" ] }, { "id" : "ITEM-2", "itemData" : { "DOI" : 
"10.1177/1947601911408893", "ISBN" : "1947601911", "ISSN" : "1947-6027", "PMID" : 
"21779513", "abstract" : "Normal function of the p53 pathway is ubiquitously lost in cancers 
either through mutation or inactivating interaction with viral or cellular proteins. However, 
it is difficult in clinical studies to link p53 mutation status to cancer treatment and clinical 
outcome, suggesting that the p53 pathway is not fully understood. We have recently 
reported that the human p53 gene expresses not only 1 but 12 different p53 proteins 
(isoforms) due to alternative splicing, alternative initiation of translation, and alternative 
promoter usage. p53 isoform proteins thus contain distinct protein domains. They are 
expressed in normal human tissues but are abnormally expressed in a wide range of cancer 
types. We have recently reported that p53 isoform expression is associated with breast 
cancer prognosis, suggesting that they play a role in carcinogenesis. Indeed, the cellular 
response to damages can be switched from cell cycle arrest to apoptosis by only 
manipulating p53 isoform expression. This may provide an explanation to the hitherto 
inconsistent relationship between p53 mutation, treatment response, and outcome in 
breast cancer. However, the molecular mechanism is still unknown. Recent reports suggest 
that it involves modulation of gene expression in a p53-dependent and -independent 
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manner. In this review, we summarize our current knowledge about the biological activities 
of p53 isoforms and propose a molecular mechanism conciliating our current knowledge on 
p53 and integrating p63 and p73 isoforms in the p53 pathway.", "author" : [ { "dropping-
particle" : "", "family" : "Khoury", "given" : "Marie P", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Bourdon", "given" : "Jean-
Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-
title" : "Genes & cancer", "id" : "ITEM-2", "issue" : "4", "issued" : { "date-parts" : [ [ "2011" ] ] 
}, "page" : "453-65", "title" : "p53 Isoforms: An Intracellular Microprocessor?", "type" : 
"article-journal", "volume" : "2" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=b46dbe63-aad3-455b-a645-16cb306ba816" 
] } ], "mendeley" : { "formattedCitation" : "(47,48)", "plainTextFormattedCitation" : 
"(47,48)", "previouslyFormattedCitation" : "(47,48)" }, "properties" : { "noteIndex" : 0 }, 
"schema" : "https://github.com/citation-style-language/schema/raw/master/csl-
citation.json" }}  
 
3.5 Role of p53 Isoforms in Regeneration 
 
Because regeneration and tumorigenesis share common molecular pathways, p53 pathway 
plays a major role in controlling regeneration. It is known that fluctuations in expression 
ratio of different p53 isoforms are involved in tissue and organ regeneration. For example, 
in mouse, the genetic investigation of one of the p53 isoforms - M41p53 (also named 
p44), which is the mouse counterpart of the human 40p53, has revealed that M41p53  
increased expression compared to the other p53 isoforms promote premature ageing 
phenotype, neurodegeneration,  atherosclerosis, osteoporosis and impaired -cell 
proliferation. However, mice did not develop cancer (4,65).   
 
 
3.6 Additional Notable Biological Functions 
 
The expression of isoforms under certain cellular conditions is still under research – 
however it is known that under standard cellular conditions, p53 and 133p53 can be co-
expressed. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", "PMID" : "16131611", 
"abstract" : "The recently discovered p53-related genes, p73 and p63, express multiple 
splice variants and N-terminally truncated forms initiated from an alternative promoter in 
intron 3. To date, no alternative promoter and multiple splice variants have been described 
for the p53 gene. In this study, we show that p53 has a gene structure similar to the p73 and 
p63 genes. The human p53 gene contains an alternative promoter and transcribes multiple 
splice variants. We show that p53 variants are expressed in normal human tissue in a tissue-
dependent manner. We determine that the alternative promoter is conserved through 
evolution from Drosophila to man, suggesting that the p53 family gene structure plays an 
essential role in the multiple activities of the p53 family members. Consistent with this 
hypothesis, p53 variants are differentially expressed in human breast tumors compared with 
normal breast tissue. We establish that p53beta can bind differentially to promoters and 
can enhance p53 target gene expression in a promoter-dependent manner, while 
Delta133p53 is dominant-negative toward full-length p53, inhibiting p53-mediated 
apoptosis. The differential expression of the p53 isoforms in human tumors may explain the 
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difficulties in linking p53 status to the biological properties and drug sensitivity of human 
cancer.", "author" : [ { "dropping-particle" : "", "family" : "Bourdon", "given" : "Jean 
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"Mark K.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Lane", "given" : "David P.", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" } ], "container-title" : "Genes and Development", "id" : "ITEM-1", 
"issue" : "18", "issued" : { "date-parts" : [ [ "2005" ] ] }, "page" : "2122-2137", "title" : "p53 
isoforms can regulate p53 transcriptional activity", "type" : "article-journal", "volume" : "19" 
}, "uris" : [ "http://www.mendeley.com/documents/?uuid=87bfab4c-0377-4811-b35f-
c1e089298fe3" ] } ], "mendeley" : { "formattedCitation" : "(34)", 
"plainTextFormattedCitation" : "(34)", "previouslyFormattedCitation" : "(34)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} More recently, it was discovered that 
levels of both p53 and 40p53 increase under conditions of glucose deprivation; 
achieved through the IRES – mediated translation of mRNA (i). IRES translation for p53 in 
general appears to occur under situations of cellular stress. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1038/cdd.2014.220", "ISBN" : 
"1476-5403 (Electronic)\\r1350-9047 (Linking)", "ISSN" : "1476-5403", "PMID" : "25721046", 
"abstract" : "Tumor suppressor protein p53 is a master transcription regulator, 
indispensable for controlling several cellular pathways. Earlier work in our laboratory led to 
the identification of dual internal ribosome entry site (IRES) structure of p53 mRNA that 
regulates translation of full-length p53 and \u039440p53. IRES-mediated translation of both 
isoforms is enhanced under different stress conditions that induce DNA damage, ionizing 
radiation and endoplasmic reticulum stress, oncogene-induced senescence and cancer. In 
this study, we addressed nutrient-mediated translational regulation of p53 mRNA using 
glucose depletion. In cell lines, this nutrient-depletion stress relatively induced p53 IRES 
activities from bicistronic reporter constructs with concomitant increase in levels of p53 
isoforms. Surprisingly, we found scaffold/matrix attachment region-binding protein 1 
(SMAR1), a predominantly nuclear protein is abundant in the cytoplasm under glucose 
deprivation. Importantly under these conditions polypyrimidine-tract-binding protein, an 
established p53 ITAF did not show nuclear-cytoplasmic relocalization highlighting the 
novelty of SMAR1-mediated control in stress. In vivo studies in mice revealed starvation-
induced increase in SMAR1, p53 and \u039440p53 levels that was reversible on dietary 
replenishment. SMAR1 associated with p53 IRES sequences ex vivo, with an increase in 
interaction on glucose starvation. RNAi-mediated-transient SMAR1 knockdown decreased 
p53 IRES activities in normal conditions and under glucose deprivation, this being reflected 
in changes in mRNAs in the p53 and \u039440p53 target genes involved in cell-cycle arrest, 
metabolism and apoptosis such as p21, TIGAR and Bax. This study provides a new 
physiological insight into the regulation of this critical tumor suppressor in nutrient 
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starvation, also suggesting important functions of the p53 isoforms in these conditions as 
evident from the downstream transcriptional target activation.Cell Death and 
Differentiation advance online publication, 27 February 2015; doi:10.1038/cdd.2014.220.", 
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"7", "issued" : { "date-parts" : [ [ "2015" ] ] }, "page" : "1-16", "title" : "Reversible induction 
of translational isoforms of p53 in glucose deprivation.", "type" : "article-journal", "volume" 
: "22" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=b2bf4047-fc0c-435e-b588-
cee59565f874" ] }, { "id" : "ITEM-2", "itemData" : { "DOI" : 
"10.1080/23723556.2015.1039689", "ISSN" : "2372-3556", "PMID" : "27308557", "abstract" 
: "p53 and its isoforms are integral in modulating transcriptional gene expression programs 
and maintaining cellular homeostasis. We recently reported that glucose deprivation/caloric 
restriction induced translational control of p53 mRNA by scaffold/matrix attachment region 
binding-protein 1 (SMAR1), adding a cytoplasmic role of SMAR1 to its traditional nuclear 
role as a transcription factor.", "author" : [ { "dropping-particle" : "", "family" : "Khan", 
"given" : "Debjit", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Chattopadhyay", "given" : "Samit", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Das", 
"given" : "Saumitra", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Molecular & Cellular Oncology", "id" : "ITEM-2", "issue" : "1", "issued" : { 
"date-parts" : [ [ "2016", "1", "2" ] ] }, "page" : "e1039689", "title" : "Influence of metabolic 
stress on translation of p53 isoforms", "type" : "article-journal", "volume" : "3" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=f77735da-94a3-37b4-bcef-465c522c81a3" ] 
} ], "mendeley" : { "formattedCitation" : "(49,50)", "plainTextFormattedCitation" : "(49,50)", 
"previouslyFormattedCitation" : "(49,50)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
 
Bourdon et al (2005) also researched the activity of p53 in the presence of p53, divulging 
notable results. p53 preferentially binds to the promoter of MDM2, but not to the pro – 
apoptotic BAX; a contrast to p53 which appears to bind avidly to BAX / p21 promoters 
rather than MDM2 – a result suggesting that the p53 isoform plays a significant role in 
enhancing p53 transcription upon the BAX promoter. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1101/gad.1339905", "ISBN" : 
"2514458412", "ISSN" : "08909369", "PMID" : "16131611", "abstract" : "The recently 
discovered p53-related genes, p73 and p63, express multiple splice variants and N-
terminally truncated forms initiated from an alternative promoter in intron 3. To date, no 
alternative promoter and multiple splice variants have been described for the p53 gene. In 
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this study, we show that p53 has a gene structure similar to the p73 and p63 genes. The 
human p53 gene contains an alternative promoter and transcribes multiple splice variants. 
We show that p53 variants are expressed in normal human tissue in a tissue-dependent 
manner. We determine that the alternative promoter is conserved through evolution from 
Drosophila to man, suggesting that the p53 family gene structure plays an essential role in 
the multiple activities of the p53 family members. Consistent with this hypothesis, p53 
variants are differentially expressed in human breast tumors compared with normal breast 
tissue. We establish that p53beta can bind differentially to promoters and can enhance p53 
target gene expression in a promoter-dependent manner, while Delta133p53 is dominant-
negative toward full-length p53, inhibiting p53-mediated apoptosis. The differential 
expression of the p53 isoforms in human tumors may explain the difficulties in linking p53 
status to the biological properties and drug sensitivity of human cancer.", "author" : [ { 
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"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}  
 
More recently, the link between induced pluripotent stem cells (iPS) and 133p53 was 
studied. iPS cells are cells that have been reprogrammed back into a pluripotent state, 
opening up the specialisation of any cell type and thus expanding the potential in 
regenerative medicine. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1016/j.cell.2007.11.019", "ISBN" : "0092-8674 (Print) 0092-8674 
(Linking)", "ISSN" : "0092-8674", "PMID" : "18035408", "abstract" : "Takahashi, K., Tanabe, 
K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of 
pluripotent stem cells from adult human fibroblasts by defined factors. cell, 131(5), 861-
872.", "author" : [ { "dropping-particle" : "", "family" : "Takahashi", "given" : "K.", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Tanabe", "given" : "K.", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Ohnuki", "given" : "M.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Narita", "given" : "M.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Ichisaka", "given" : "T.", "non-dropping-particle" : "", 
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"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Tomoda", "given" : 
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"suffix" : "" } ], "container-title" : "Cell", "id" : "ITEM-1", "issue" : "5", "issued" : { "date-
parts" : [ [ "2007" ] ] }, "page" : "861-872", "title" : "Induction of Pluripotent Stem Cells from 
Adult Human Fibroblasts by Defined Factors", "type" : "article-journal", "volume" : "107" }, 
"uris" : [ "http://www.mendeley.com/documents/?uuid=2f7c55fd-5991-445f-8cfe-
55be8fc2f2ea" ] } ], "mendeley" : { "formattedCitation" : "(51)", 
"plainTextFormattedCitation" : "(51)", "previouslyFormattedCitation" : "(51)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} During cell reprogramming, the quantity 
of 133p53 increased, suggesting that the isoform contributes to such a function – and 
concurring with other research, elevated levels of 133p53 appear to arrest apoptosis 
during the reprogramming of iPS cells and increasing genome intergrity. Other effects of 
133p53 ascertained include assisting DNA double strand break repair (by stimulating the 
expression of RAD51, LIG4 and RAD52) and its presence correlating to a lower rate of 
chromosomal abnormalities within iPS cells. {ADDIN CSL_CITATION { "citationItems" : [ { "id" 
: "ITEM-1", "itemData" : { "DOI" : "10.1038/srep37281", "ISSN" : "2045-2322", "PMID" : 
"27874035", "abstract" : "Human induced pluripotent stem (iPS) cells have great potential in 
regenerative medicine, but this depends on the integrity of their genomes. iPS cells have 
been found to contain a large number of de novo genetic alterations due to DNA damage 
response during reprogramming. Thus, to maintain the genetic stability of iPS cells is an 
important goal in iPS cell technology. DNA damage response can trigger tumor suppressor 
p53 activation, which ensures genome integrity of reprogramming cells by inducing 
apoptosis and senescence. p53 isoform \u0394133p53 is a p53 target gene and functions to 
not only antagonize p53 mediated apoptosis, but also promote DNA double-strand break 
(DSB) repair. Here we report that \u0394133p53 is induced in reprogramming. Knockdown 
of \u0394133p53 results 2-fold decrease in reprogramming efficiency, 4-fold increase in 
chromosomal aberrations, whereas overexpression of \u0394133p53 with 4 Yamanaka 
factors showes 4-fold increase in reprogamming efficiency and 2-fold decrease in 
chromosomal aberrations, compared to those in iPS cells induced only with 4 Yamanaka 
factors. Overexpression of \u0394133p53 can inhibit cell apoptosis and promote DNA DSB 
repair foci formation during reprogramming. Our finding demonstrates that the 
overexpression of \u0394133p53 not only enhances reprogramming efficiency, but also 
results better genetic quality in iPS cells.", "author" : [ { "dropping-particle" : "", "family" : 
"Gong", "given" : "Lu", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
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"Haide", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Rao", "given" : "Lingjun", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Zeng", "given" : "Yelin", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Hang", "given" : "Honghui", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Peng", "given" : "Jinrong", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Xiao", 
"given" : "Lei", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Chen", "given" : "Jun", "non-dropping-particle" : "", "parse-names" : 
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false, "suffix" : "" } ], "container-title" : "Scientific Reports", "id" : "ITEM-1", "issue" : "July", 
"issued" : { "date-parts" : [ [ "2016" ] ] }, "page" : "37281", "title" : "P53 Isoform 
\u0394133P53 Promotes Efficiency of Induced Pluripotent Stem Cells and Ensures Genomic 
Integrity During Reprogramming", "type" : "article-journal", "volume" : "6" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=acd2d9d8-2985-49be-819c-9e611c888281" 
] } ], "mendeley" : { "formattedCitation" : "(52)", "plainTextFormattedCitation" : "(52)", 
"previouslyFormattedCitation" : "(52)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}.  
 
 
4- Link Between p53 pathway and Cancer 
 
It is established that TP53 is the most frequently mutated gene in human cancers and that 
when TP53 is not mutated, WT TP53 activities are compromised in almost all tumours. (70-
73). Moreover, mutant p53 has an oncogenic potential because it would act as a 
dominant-negative inhibitor toward wild-type p53. (70) 
 
The role of TP53 in the development of many forms of malignancy has recently been 
highlighted by the International Cancer Genome Consortium (IGCC). As of the 3rd August 
2017, the IGCC have released data from more than 17500 cancer donors demonstrating that 
TP53 is by far the most commonly mutated gene in cancer. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "URL" : "https://dcc.icgc.org/", "accessed" 
: { "date-parts" : [ [ "2017", "8", "3" ] ] }, "id" : "ITEM-1", "issued" : { "date-parts" : [ [ "0" ] ] }, 
"title" : "Welcome | ICGC Data Portal", "type" : "webpage" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=7f5c6211-8d18-35ca-82bc-4110acf3c0ef" ] } 
], "mendeley" : { "formattedCitation" : "(68)", "plainTextFormattedCitation" : "(68)", 
"previouslyFormattedCitation" : "(68)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
 
 
4.1 Human Papilloma Virus and p53 
 
As mentioned, nearly all cervical cancer cases are linked to persistent infection with HPV - 
three genes out of eight within HPV16 are significant in this progression. They are E2, E6 and 
E7. E6 is a viral oncogene that mediates the degradation of p53 whilst E7, also a viral 
oncogene, binds to and inactivates pRB (another tumour suppression protein). Significant 
evidence exists to suggest that a key role in the development of cervical cancer is the loss of 
the viral E2 gene. The E2 gene is a viral tumour suppressor, stifling the activities of E6 and E7 
– an observation confirmed by its absence in cervical tumours. {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1158/0008-5472.CAN-07-
2754", "ISBN" : "1538-7445 (Electronic) 0008-5472 (Linking)", "ISSN" : "00085472", "PMID" : 
"18172324", "abstract" : "Chromosomal integration of high-risk human papillomavirus (HR-
HPV) genomes is believed to represent a significant event in the pathogenesis of cervical 
cancer associated with progression from preneoplastic lesions to invasive carcinomas. This 
hypothesis is based on experimental data suggesting that integration-dependent disruption 
of HR-HPV E2 gene functions is important to achieve neoplastic transformation and on 
clinical data gathered by analyzing lesions induced by human papillomavirus (HPV) 16 and 
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18 that revealed integrated viral genome copies in the vast majority of cervical cancer cells. 
However, a substantial fraction of cervical cancers is associated with other HR-HPV types for 
which virtually no data concerning their integration status have been reported so far. Here, 
we compared integration frequencies of the five most common oncogenic HPV types 
(HPV16, 18, 31, 33, and 45) in a series of 835 cervical samples using a specific mRNA-based 
PCR assay (Amplification of Papillomavirus Oncogene Transcripts). Most precancerous 
lesions displayed exclusively episomal viral genomes, whereas 62% of the carcinomas had 
integrated viral genomes. However, the frequency of integrated HR-HPV genomes showed 
marked differences for individual HR-HPV types. HPV16, 18, and 45 were found substantially 
more often in the integrated state compared with HPV types 31 and 33. The analysis of the 
median age of patients with high-grade precancerous lesions and invasive cancers suggests 
that precancers induced by HPV types 18, 16, and 45 progress to invasive cervical cancer in 
substantially less time compared with precancers induced by HPV types 31 and 33. These 
findings suggest that integration of oncogenic HPV genomes in cervical lesions is a 
consequence rather than the cause of chromosomal instability induced by deregulated HR-
HPV E6-E7 oncogene expression. Distinct HR-HPV types apparently provoke chromosomal 
instability in their host cells to a different extent than is reflected by their integration 
frequencies in advanced lesions and the time required for CIN 3 lesions to progress to 
invasive cancer.", "author" : [ { "dropping-particle" : "", "family" : "Vinokurova", "given" : 
"Svetlana", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Wentzensen", "given" : "Nicolas", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Kraus", "given" : 
"Irene", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Klaes", "given" : "Ruediger", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Driesch", "given" : 
"Corina", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Melsheimer", "given" : "Peter", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Kisseljov", "given" : 
"Fjodor", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "D\u00fcrst", "given" : "Mattias", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Schneider", "given" 
: "Achim", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Doeberitz", "given" : "Magnus Von Knebel", "non-dropping-particle" 
: "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Cancer Research", "id" : "ITEM-
1", "issue" : "1", "issued" : { "date-parts" : [ [ "2008" ] ] }, "page" : "307-313", "title" : "Type-
dependent integration frequency of human papillomavirus genomes in cervical lesions", 
"type" : "article-journal", "volume" : "68" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=ed0471c2-e91b-44e1-8cec-b3096c1129cf" ] 
} ], "mendeley" : { "formattedCitation" : "(70)", "plainTextFormattedCitation" : "(70)", 
"previouslyFormattedCitation" : "(70)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} When 
it ceases to function, the uncontrollable transcription of genes E6 and E7 occur, resulting in 
decreased expression of pRB and p53 {ADDIN CSL_CITATION { "citationItems" : [ { "id" : 
"ITEM-1", "itemData" : { "DOI" : "10.4143/crt.2005.37.6.319", "ISBN" : "2005-9256 
(Electronic)\\n1598-2998 (Linking)", "ISSN" : "2005-9256", "PMID" : "19956366", "abstract" : 
"Cervical cancer is one of the leading world causes of cancer morbidity and mortality in 
woman, with more than 98% related to a human papillomavirus (HPV) infection origin. 
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Infection with specific subtypes of HPV has been strongly implicated in cervical 
carcinogenesis. The identification and functional verification of host proteins associated 
with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical 
carcinogenesis and the development of cervical cancer-specific markers. The advent of 
functional genomics and proteomics has provided hope of discovering novel biological 
markers for use in the screening, early diagnosis, prognostication and prediction of response 
to therapy. Herein, we review the studies where the profiles of host proteins associated 
with HPV E6 and E7 oncoproteins in cervical cancer were generated.", "author" : [ { 
"dropping-particle" : "", "family" : "Yim", "given" : "Eun-Kyoung", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Park", "given" : 
"Jong-Sup", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-
title" : "Cancer research and treatment : official journal of Korean Cancer Association", "id" : 
"ITEM-1", "issue" : "6", "issued" : { "date-parts" : [ [ "2005" ] ] }, "page" : "319-24", "title" : 
"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis.", "type" 
: "article-journal", "volume" : "37" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=53618b76-e87b-42b8-b946-4566f538eb27" 
] }, { "id" : "ITEM-2", "itemData" : { "ISBN" : "2156-6976 (Electronic)", "PMID" : "21968515", 
"abstract" : "The papillomavirus (PV) E2 proteins have been shown to exert many functions 
in the viral cycle including pivotal roles in transcriptional regulation and in viral DNA 
replication. Besides these historical roles, which rely on their aptitude to bind to specific 
DNA sequences, E2 has also been shown to modulate the host cells through direct protein 
interactions mainly through its amino terminal transactivation domain. We will describe 
here some of these new functions of E2 and their potential implication in the HPV-induced 
carcinogenesis. More particularly we will focus on E2-mediated modulation of the host cell 
cycle and consequences to cell transformation. In all, the HPV E2 proteins exhibit complex 
functions independent of transcription that can modulate the host cells in concert with the 
viral vegetative cycle and which could be involved in early carcinogenesis.", "author" : [ { 
"dropping-particle" : "", "family" : "Bellanger", "given" : "S", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Tan", "given" : "C 
L", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : 
"", "family" : "Xue", "given" : "Y Z", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Teissier", "given" : "S", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Thierry", "given" : "F", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Am J Cancer Res", "id" : "ITEM-2", "issued" : { "date-parts" : [ [ "2011" ] ] 
}, "page" : "373-389", "title" : "Tumor suppressor or oncogene? A critical role of the human 
papillomavirus (HPV) E2 protein in cervical cancer progression", "type" : "article-journal", 
"volume" : "1" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=b29f495a-0aa3-
4cbb-83b4-af8bc15cd302" ] } ], "mendeley" : { "formattedCitation" : "(61,71)", 
"plainTextFormattedCitation" : "(61,71)", "previouslyFormattedCitation" : "(61,71)" }, 
"properties" : { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. 
E6 degrades p53 through a pathway entitled the ubiquitin – proteasome pathway. E6 
proteins do not directly affiliate with p53, but instead reassign E6AP (E6 associated protein 
– an enzyme that targets other proteins for breakdown) to p53. This marks p53 for 
ubiquitination and proteasome degradation by 26S, explaining the uncharacteristically low 
levels of p53 in cervical cancer and thus promoting carcinogenesis by inhibiting the 
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apoptosis of malignant cells; in other words, inhibiting the role that p53 plays within cells. 
{ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.4143/crt.2005.37.6.319", "ISBN" : "2005-9256 (Electronic)\\n1598-2998 (Linking)", 
"ISSN" : "2005-9256", "PMID" : "19956366", "abstract" : "Cervical cancer is one of the 
leading world causes of cancer morbidity and mortality in woman, with more than 98% 
related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of 
HPV has been strongly implicated in cervical carcinogenesis. The identification and 
functional verification of host proteins associated with HPV E6 and E7 oncoproteins may 
provide useful information in understanding cervical carcinogenesis and the development of 
cervical cancer-specific markers. The advent of functional genomics and proteomics has 
provided hope of discovering novel biological markers for use in the screening, early 
diagnosis, prognostication and prediction of response to therapy. Herein, we review the 
studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in 
cervical cancer were generated.", "author" : [ { "dropping-particle" : "", "family" : "Yim", 
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"parse-names" : false, "suffix" : "" } ], "container-title" : "Cancer research and treatment : 
official journal of Korean Cancer Association", "id" : "ITEM-1", "issue" : "6", "issued" : { 
"date-parts" : [ [ "2005" ] ] }, "page" : "319-24", "title" : "The role of HPV E6 and E7 
oncoproteins in HPV-associated cervical carcinogenesis.", "type" : "article-journal", 
"volume" : "37" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=53618b76-e87b-
42b8-b946-4566f538eb27" ] } ], "mendeley" : { "formattedCitation" : "(61)", 
"plainTextFormattedCitation" : "(61)", "previouslyFormattedCitation" : "(61)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
4.2 Hepatitis B and p53 
 
Hepatitis B can repress p53 mediated apoptosis. The oncoprotein HBx (produced by 
hepatitis B), forms a protein complex with p53 by interacting through a sequence of 
residues in its C – terminus. This appears to occur in the cytoplasm, resulting in the arresting 
of apoptosis and thus contributing to the development of hepatocellular carcinoma. {ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1073/pnas.94.26.14707", "ISBN" : "0027-8424", "ISSN" : "0027-8424", "PMID" : 
"9405677", "abstract" : "We have reported previously that the hepa-titis B virus 
oncoprotein, HBx, can bind to the C terminus of p53 and inhibit several critical p53-
mediated cellular pro-cesses, including DNA sequence-specific binding, transcrip-tional 
transactivation, and apoptosis. Recognizing the impor-tance of p53-mediated apoptosis for 
maintaining homeostasis and preventing neoplastic transformation, here we further 
examine the physical interaction between HBx and p53 as well as the functional 
consequences of this association. In vitro binding studies indicate that the ayw and adr viral 
subtypes of HBx bind similar amounts of glutathione S-transferase-p53 with the distal C 
terminus of HBx (from residues 111 to 154) being critical for this interaction. Using a 
microinjection technique, we show that this same C-terminal region of HBx is necessary for 
sequestering p53 in the cytoplasm and abro-gating p53-mediated apoptosis. The 
transcriptional transac-tivation domain of HBx also maps to its C terminus; however, a 
comparison of the ability of full-length and truncated HBx protein to abrogate p53-induced 
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apoptosis versus transacti-vate simian virus 40-or human nitric oxide synthase-2 promoter-
driven reporter constructs indicates that these two functional properties are distinct and 
thus may contribute to hepatocarcinogenesis differently. Collectively, our data indi-cate 
that the distal C-terminal domain of HBx, independent of its transactivation activity, 
complexes with p53 in the cyto-plasm, partially preventing its nuclear entry and ability to 
induce apoptosis. These pathobiological effects of HBx may contribute to the early stages of 
hepatocellular carcinogenesis.", "author" : [ { "dropping-particle" : "", "family" : "Elmore", 
"given" : "Lynne W", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Hancock", "given" : "Amy R", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Chang", "given" 
: "Shau-Feng", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Wang", "given" : "Xin W", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Chang", "given" : "Seung", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Callahan", "given" : "Christiana P", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Geller", "given" : "David A", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Will", "given" : "Hans", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Harris", "given" : "Curtis C", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "Proc. Natl. 
Acad. Sci. USA", "id" : "ITEM-1", "issue" : "December", "issued" : { "date-parts" : [ [ "1997" ] ] 
}, "page" : "14707-14712", "title" : "Hepatitis B virus X protein and p53 tumor suppressor 
interactions in the modulation of apoptosis", "type" : "article-journal", "volume" : "94" }, 
"uris" : [ "http://www.mendeley.com/documents/?uuid=dde19e1f-e96a-471d-bfeb-
708c59d9310f" ] } ], "mendeley" : { "formattedCitation" : "(72)", 
"plainTextFormattedCitation" : "(72)", "previouslyFormattedCitation" : "(72)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
 
4.3 Mutant p53 and an Associated Specific Mutation  
 
Certain mutant p53 proteins can bind to wt p53, compromising its activities and thus 
promoting abnormal cell proliferation. It is interesting to note that complexes between 
mutant p53 and wt p53 tend to involve the oligomerization domain –{ADDIN 
CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1128/MCB.11.1.12", "ISBN" : "0270-7306 (Print)\\r0270-7306 (Linking)", "ISSN" : "0270-
7306", "PMID" : "1986215", "abstract" : "It has been suggested that the dominant effect of 
mutant p53 on tumor progression may reflect the mutant protein binding to wild-type p53, 
with inactivation of suppressor function. To date, evidence for wild-type/mutant p53 
complexes involves p53 from different species. To investigate wild-type/mutant p53 
complexes in relation to natural tumor progression, we sought to identify intraspecific 
complexes, using murine p53. The mutant phenotype p53-246(0) was used because this 
phenotype is immunologically distinct from wild-type p53-246+ and thus permits 
immunological analysis for wild-type/mutant p53 complexes. The p53 proteins were derived 
from genetically defined p53 cDNAs expressed in vitro and also from phenotypic variants of 
p53 expressed in vivo. We found that the mutant p53 phenotype was able to form a 
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complex with the wild type when the two p53 variants were cotranslated. When mixed in 
their native states (after translation), the wild-type and mutant p53 proteins did not exhibit 
any binding affinity for each other in vitro. Under identical conditions, complexes of wild-
type human and murine p53 proteins were formed. For murine p53, both the wild-type and 
mutant p53 proteins formed high-molecular-weight complexes when translated in vitro. 
This oligomerization appeared to involve the carboxyl terminus, since truncated p53 (amino 
acids 1 to 343) did not form complexes. We suggest that the ability of the mutant p53 
phenotype to complex with wild type during cotranslation may contribute to the 
transforming function of activated mutants of p53 in vivo.", "author" : [ { "dropping-particle" 
: "", "family" : "Milner", "given" : "J", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Medcalf", "given" : "E A", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Cook", "given" : "A C", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" } ], 
"container-title" : "Molecular and cellular biology", "id" : "ITEM-1", "issue" : "1", "issued" : { 
"date-parts" : [ [ "1991" ] ] }, "page" : "12-19", "title" : "Tumor suppressor p53: analysis of 
wild-type and mutant p53 complexes", "type" : "article-journal", "volume" : "11" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=66e666f5-1cb2-460a-b201-34831c1b8dbf" ] 
} ], "mendeley" : { "formattedCitation" : "(73)", "plainTextFormattedCitation" : "(73)", 
"previouslyFormattedCitation" : "(73)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}   
 
One of the more common alterations that occur upon TP53 is the R175H mutation, as 
labelled within the COSMIC database. It is a single base substitution at codon 524, 
exchanging guanine  adenine, and has a high functional impact with this mutation 
particularly occurring in colorectal cancers. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : 
"ITEM-1", "itemData" : { "URL" : 
"http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=10648", "accessed" : { "date-
parts" : [ [ "2017", "8", "3" ] ] }, "id" : "ITEM-1", "issued" : { "date-parts" : [ [ "0" ] ] }, "title" : 
"COSMIC: Mutation overview page TP53 - p.R175H ( Substitution - Missense)", "type" : 
"webpage" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=85e5ce7b-91ac-3651-
9003-0e4731ba9d54" ] } ], "mendeley" : { "formattedCitation" : "(75)", 
"plainTextFormattedCitation" : "(75)", "previouslyFormattedCitation" : "(75)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} p53 R175H impairs recruitment of ATM 
(mediated by MRN  in response to DNA double strand break damage), thus encouraging the 
proliferation of anomalies within cells. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : 
"ITEM-1", "itemData" : { "DOI" : "10.1038/onc.2009.376.A", "ISBN" : "1476-5594 
(Electronic)\\r0950-9232 (Linking)", "ISSN" : "0950-9232", "PMID" : "19881536", "abstract" : 
"The critical tumor suppressor p53 is mutated in over half of all human cancers. The 
majority of p53 cancer mutations are missense mutations, which can be classified into 
contact mutations that directly disrupt the DNA-binding of p53 but have modest impact on 
p53 conformation and structural mutations that greatly disrupt p53 conformation. Many 
p53 cancer mutants, including the hot spot mutations (R175H, R248W and R273H), not only 
lose p53-dependent tumor-suppressor activities, but also acquire new oncogenic activities 
to promote cancer. Therefore, it is critical to elucidate the gain of oncogenic function of p53 
cancer mutants. Using humanized p53-mutant knock-in mouse models, we have identified a 
gain of oncogenic function shared by the most common p53 contact mutants (R273H and 
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R248W) and structural mutant (R175H). This gain of function inactivates Mre11/ATM-
dependent DNA damage responses, leading to chromosomal translocation and defective 
G(2)/M checkpoint. Considering the critical roles of ATM in maintaining genetic stability and 
therapeutic responses to many cancer treatments, the identification of this common gain of 
function of p53 cancer mutants will have important implication on the drug resistance of a 
significant portion of human cancers that express either the contact or structural p53 cancer 
mutants.", "author" : [ { "dropping-particle" : "", "family" : "Liu", "given" : "D P", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Song", "given" : "H", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Xu", "given" : "Y", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" } ], "container-title" : "Oncogene", "id" : "ITEM-1", "issue" 
: "7", "issued" : { "date-parts" : [ [ "2010" ] ] }, "page" : "949-956", "title" : "A common gain 
of function of p53 cancer mutants in inducing genetic instability.", "type" : "article-journal", 
"volume" : "29" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=cd064754-933f-
4281-b0aa-1036aaaf5a3c" ] } ], "mendeley" : { "formattedCitation" : "(76)", 
"plainTextFormattedCitation" : "(76)", "previouslyFormattedCitation" : "(76)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} It is relevant to mention that R175H 
occurs within the DNA Binding Domain of p53 proteins – it is within the DBD that the 
majority of mutations occur. 
 
4.4 Other Interactions of Mutant p53 
 
As mentioned, mutant p53 can bind to wtp53, altering its transcriptional activity. An 
example of this relates to p63, a family member of TP53 gene. Briefly, mutant p53 can 
inhibit the activity of p63 protein isoforms which then results in the unregulated expression 
of genes such as DICER1, SHARP1 and CCNG2. The abnormal expression of these genes 
enhances the release of growth receptors and integrins, leading to increased and 
uncontrolled cell division. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1038/ncb2641", "ISBN" : "1476-4679", "ISSN" : "1465-7392", 
"PMID" : "23263379", "abstract" : "In the past fifteen years, it has become apparent that 
tumour-associated\\np53 mutations can provoke activities that are different to 
those\\nresulting from simply loss of wild-type tumour-suppressing p53 function.\\nMany 
of these mutant p53 proteins acquire oncogenic properties that\\nenable them to promote 
invasion, metastasis, proliferation and cell\\nsurvival. Here we highlight some of the 
emerging molecular mechanisms\\nthrough which mutant p53 proteins can exert these 
oncogenic functions.", "author" : [ { "dropping-particle" : "", "family" : "Muller", "given" : 
"Patricia A J", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Vousden", "given" : "Karen H", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" } ], "container-title" : "Nature Cell Biology", "id" : "ITEM-1", 
"issue" : "1", "issued" : { "date-parts" : [ [ "2013" ] ] }, "page" : "2-8", "title" : "p53 mutations 
in cancer", "type" : "article-journal", "volume" : "15" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=8dc72922-5fe5-4edd-8a7a-45b5e95565fc" ] 
} ], "mendeley" : { "formattedCitation" : "(78)", "plainTextFormattedCitation" : "(78)", 
"previouslyFormattedCitation" : "(78)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
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Whilst mutant p53 interacts with many proteins (all of which cannot be mentioned), one 
that is important to reference is its interaction with the SWI / SNF complex. Established as a 
nucleosome remodelling complex, it is a collection of proteins that interact with the 
packaging process of DNA, altering DNA interaction with histones and thus gene 
transcription. Mutant p53 relies upon the SWI / SNF complex to displace nucleosomes that 
regulates thus DNA accessibility for transcription factors, explaining how mutant p53 can 
promote the plasticity of cancers, being able to trans-differentiate  or de -differentiate with 
ease and thus escape treatment. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1101/gad.263202.115", "ISSN" : "1549-5477", "PMID" : 
"26080815", "abstract" : "Mutant p53 impacts the expression of numerous genes at the 
level of transcription to mediate oncogenesis. We identified vascular endothelial growth 
factor receptor 2 (VEGFR2), the primary functional VEGF receptor that mediates endothelial 
cell vascularization, as a mutant p53 transcriptional target in multiple breast cancer cell 
lines. Up-regulation of VEGFR2 mediates the role of mutant p53 in increasing cellular growth 
in two-dimensional (2D) and three-dimensional (3D) culture conditions. Mutant p53 binds 
near the VEGFR2 promoter transcriptional start site and plays a role in maintaining an open 
conformation at that location. Relatedly, mutant p53 interacts with the SWI/SNF complex, 
which is required for remodeling the VEGFR2 promoter. By both querying individual genes 
regulated by mutant p53 and performing RNA sequencing, the results indicate that >40% of 
all mutant p53-regulated gene expression is mediated by SWI/SNF. We surmise that mutant 
p53 impacts transcription of VEGFR2 as well as myriad other genes by promoter remodeling 
through interaction with and likely regulation of the SWI/SNF chromatin remodeling 
complex. Therefore, not only might mutant p53-expressing tumors be susceptible to anti 
VEGF therapies, impacting SWI/SNF tumor suppressor function in mutant p53 tumors may 
also have therapeutic potential.", "author" : [ { "dropping-particle" : "", "family" : "Pfister", 
"given" : "Neil T", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Fomin", "given" : "Vitalay", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Regunath", "given" 
: "Kausik", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Zhou", "given" : "Jeffrey Y", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Zhou", "given" : "Wen", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Silwal-Pandit", "given" : "Laxmi", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Freed-Pastor", "given" : "William A", 
"non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Laptenko", "given" : "Oleg", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Neo", "given" : "Suat Peng", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Bargonetti", "given" : "Jill", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Hoque", "given" : "Mainul", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Tian", "given" : "Bin", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Gunaratne", "given" : "Jayantha", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Engebraaten", "given" : "Olav", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Manley", "given" : "James L", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
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"B\u00f8rresen-Dale", "given" : "Anne-Lise", "non-dropping-particle" : "", "parse-names" : 
false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Neilsen", "given" : "Paul M", "non-
dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", 
"family" : "Prives", "given" : "Carol", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" } ], "container-title" : "Genes & development", "id" : "ITEM-1", "issue" : "12", 
"issued" : { "date-parts" : [ [ "2015", "6", "15" ] ] }, "page" : "1298-315", "publisher" : "Cold 
Spring Harbor Laboratory Press", "title" : "Mutant p53 cooperates with the SWI/SNF 
chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.", "type" : "article-
journal", "volume" : "29" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=afc2664a-59b5-3587-bafe-a25b2712b9d6" ] 
} ], "mendeley" : { "formattedCitation" : "(79)", "plainTextFormattedCitation" : "(79)", 
"previouslyFormattedCitation" : "(79)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }} 
 
5- Relevance of p53 Isoforms to Cancer 
 
5.1 Breast Tumours 
 
In 2005, whilst researching the isoforms, Bourdon et al also identified the abnormal 
expression of isoforms within breast tumours. Within normal breast tissue, the co-
expression of p53, p53 and p53 mRNA was detected but none of the 133p53 isoforms 
mRNAs. However, an interesting observation was noted within the breast tumours (of which 
30 were investigated) - p53, 133p53 and 133p53 were absent from the breast cancer 
tissue; p53 was detected in only 10 out of 30. Interestingly however, 133p53 was co-
expressed in 24 out of the 30 tumours – an indication that this isoform may play a role in 
the development of certain malignancies. Out of all 30 breast tumours, only 5 expressed 
mutant TP53, suggesting that the isoforms may play a greater role in tumorigenesis than 
TP53 mutation. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { 
"DOI" : "10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", "PMID" : 
"16131611", "abstract" : "The recently discovered p53-related genes, p73 and p63, express 
multiple splice variants and N-terminally truncated forms initiated from an alternative 
promoter in intron 3. To date, no alternative promoter and multiple splice variants have 
been described for the p53 gene. In this study, we show that p53 has a gene structure 
similar to the p73 and p63 genes. The human p53 gene contains an alternative promoter 
and transcribes multiple splice variants. We show that p53 variants are expressed in normal 
human tissue in a tissue-dependent manner. We determine that the alternative promoter is 
conserved through evolution from Drosophila to man, suggesting that the p53 family gene 
structure plays an essential role in the multiple activities of the p53 family members. 
Consistent with this hypothesis, p53 variants are differentially expressed in human breast 
tumors compared with normal breast tissue. We establish that p53beta can bind 
differentially to promoters and can enhance p53 target gene expression in a promoter-
dependent manner, while Delta133p53 is dominant-negative toward full-length p53, 
inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human 
tumors may explain the difficulties in linking p53 status to the biological properties and drug 
sensitivity of human cancer.", "author" : [ { "dropping-particle" : "", "family" : "Bourdon", 
"given" : "Jean Christophe", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Fernandes", "given" : "Kenneth", "non-dropping-
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particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Murray-Zmijewski", "given" : "Fiona", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Liu", "given" : "Geng", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Diot", 
"given" : "Alexandra", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Xirodimas", "given" : "Dimitris P.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Saville", "given" : "Mark K.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Lane", "given" : "David P.", "non-dropping-particle" : 
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"title" : "p53 isoforms can regulate p53 transcriptional activity", "type" : "article-journal", 
"volume" : "19" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=87bfab4c-0377-
4811-b35f-c1e089298fe3" ] } ], "mendeley" : { "formattedCitation" : "(34)", 
"plainTextFormattedCitation" : "(34)", "previouslyFormattedCitation" : "(34)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} 
 
Consistently, a more recent study of 127 breast tumours revealed that only 36% of breast 
tumours recorded p53 expression, 37% of breast tumours expressed p53 and 19% of 
tumours co-expressed both p53 and p53. (85) 
 
It was also found that the expression of both isoforms was not random – indeed, their 
expression was linked. The mutant TP53 breast cancer patients co-expressing p53 also had 
better prognosis than mutant TP53 patients not expressing p53. Patients that did not 
produce p53 were, in fact, reported to have a particularly poor prognosis. (85) 
 
 
5.2 133p53 Isoforms 
 
When co-expressed with other p53 isoforms, 133p53 has been shown to play a role in 
the regulation of apoptosis (a major function of p53) in colorectal cancer cells through its 
connection with the anti – apoptotic protein, RhoB. When bound to RhoB, it inhibits the 
activity of RhoB and so, in the case of colorectal cancer cells, shields it from apoptosis (since 
RhoB is considered a tumour suppressor gene).  {ADDIN CSL_CITATION { "citationItems" : [ { 
"id" : "ITEM-1", "itemData" : { "DOI" : "10.1371/journal.pone.0172125", "ISSN" : "1932-
6203", "PMID" : "28212429", "abstract" : "The TP53 gene plays essential roles in cancer. 
Conventionally, wild type (WT) p53 is thought to prevent cancer development and 
metastasis formation, while mutant p53 has transforming abilities. However, clinical studies 
failed to establish p53 mutation status as an unequivocal predictive or prognostic factor of 
cancer progression. The recent discovery of p53 isoforms that can differentially regulate cell 
cycle arrest and apoptosis suggests that their expression, rather than p53 mutations, could 
be a more clinically relevant biomarker in patients with cancer. In this study, we show that 
the p53 isoform delta133p53\u00df is involved in regulating the apoptotic response in 
colorectal cancer cell lines. We first demonstrate delta133p53\u00df association with the 
small GTPase RhoB, a well-described anti-apoptotic protein. We then show that, by 
inhibiting RhoB activity, delta133p53\u00df protects cells from camptothecin-induced 
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apoptosis. Moreover, we found that high delta133p53 mRNA expression levels are 
correlated with higher risk of recurrence in a series of patients with locally advanced rectal 
cancer (n = 36). Our findings describe how a WT TP53 isoform can act as an oncogene and 
add a new layer to the already complex p53 signaling network.", "author" : [ { "dropping-
particle" : "", "family" : "Arsic", "given" : "Nikola", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Ho-Pun-Cheung", "given" : 
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"publisher" : "Public Library of Science", "title" : "The p53 isoform delta133p53\u00df 
regulates cancer cell apoptosis in a RhoB-dependent manner.", "type" : "article-journal", 
"volume" : "12" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=d9aa21b5-5b66-
366e-bc43-ccb27fd03644" ] } ], "mendeley" : { "formattedCitation" : "(82)", 
"plainTextFormattedCitation" : "(82)", "previouslyFormattedCitation" : "(82)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }} This results in the inevitable conclusion 
of it being a stimulant of tumourigenesis. 
Linking in with breast tumours, it was discovered that 133p53 co-expression with p53 
isoforms was also interrelated to the stage of breast cancer and thus a worse prognosis – 
whilst the 133p53 and 133p53 isoforms displayed no such association. It was also 
identified that in breast tumours where 133p53 and/or 133p53 was detected, 
133p53 was always present. Perhaps the most interesting discovery, however, was the 
observation that expression of 133p53 isoforms seemingly drives invasion in breast cancer 
cells. MDA-MB-231 D3H2LN cells, when paralleled with the parental form MDA-MB-231, 
showed a higher metastatic potential; the D3H2LN cells express at the endogenous level a 
higher amount of 133p53 protein than the parental MDA-MD-231 cells. This was 
confirmed when re-introduction of mutant Δ133p53β-R280K isoforms in D3H2LN cells 
previously depleted in Δ133p53β isoform; began to invade. A reduction in levels of the 133 
or  isoform variants stalled invasion drastically {ADDIN CSL_CITATION { "citationItems" : [ { 
"id" : "ITEM-1", "itemData" : { "DOI" : "10.7554/eLife.14734", "ISSN" : "2050084X", "PMID" : 
"27630122", "abstract" : "TP53 is conventionally thought to prevent cancer formation and 
progression to metastasis, while mutant TP53 has transforming activities. However, in the 
clinic, TP53 mutation status does not accurately predict cancer progression. Here we report, 
based on clinical analysis corroborated with experimental data, that the p53 isoform 
\u0394133p53\u03b2 promotes cancer cell invasion, regardless of TP53 mutation status. 
\u0394133p53\u03b2 increases risk of cancer recurrence and death in breast cancer 
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patients. Furthermore \u0394133p53\u03b2 is critical to define invasiveness in a panel of 
breast and colon cell lines, expressing WT or mutant TP53. Endogenous mutant 
\u0394133p53\u03b2 depletion prevents invasiveness without affecting mutant full-length 
p53 protein expression. Mechanistically WT and mutant \u0394133p53\u03b2 induces EMT. 
Our findings provide explanations to 2 long-lasting and important clinical conundrums: how 
WT TP53 can promote cancer cell invasion and reciprocally why mutant TP53 gene does not 
systematically induce cancer progression.", "author" : [ { "dropping-particle" : "", "family" : 
"Gadea", "given" : "Gilles", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, 
{ "dropping-particle" : "", "family" : "Arsic", "given" : "Nikola", "non-dropping-particle" : "", 
"parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Fernandes", "given" 
: "Kenneth", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-
particle" : "", "family" : "Diot", "given" : "Alexandra", "non-dropping-particle" : "", "parse-
names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Joruiz", "given" : 
"S\u00e9bastien M.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Abdallah", "given" : "Samer", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Meuray", 
"given" : "Valerie", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Vinot", "given" : "St\u00e9phanie", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Anguille", "given" : "Christelle", "non-dropping-particle" : "", "parse-names" : false, "suffix" 
: "" }, { "dropping-particle" : "", "family" : "Remenyi", "given" : "Judit", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Khoury", "given" : "Marie P.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : 
"" }, { "dropping-particle" : "", "family" : "Quinlan", "given" : "Philip R.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Purdie", "given" : "Colin A.", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" 
}, { "dropping-particle" : "", "family" : "Jordan", "given" : "Lee B.", "non-dropping-particle" : 
"", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "V.", "family" : "Fuller-Pace", 
"given" : "Frances", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Toledo", "given" : "Marion", "non-dropping-particle" : 
"De", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : "Cren", 
"given" : "Ma\u00eflys", "non-dropping-particle" : "", "parse-names" : false, "suffix" : "" }, { 
"dropping-particle" : "", "family" : "Thompson", "given" : "Alastair M.", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" }, { "dropping-particle" : "", "family" : 
"Bourdon", "given" : "Jean Christophe", "non-dropping-particle" : "", "parse-names" : false, 
"suffix" : "" }, { "dropping-particle" : "", "family" : "Roux", "given" : "Pierre", "non-dropping-
particle" : "", "parse-names" : false, "suffix" : "" } ], "container-title" : "eLife", "id" : "ITEM-1", 
"issue" : "September2016", "issued" : { "date-parts" : [ [ "2016" ] ] }, "title" : "TP53 drives 
invasion through expression of its \u0394133p53\u03b2 variant", "type" : "article-journal", 
"volume" : "5" }, "uris" : [ "http://www.mendeley.com/documents/?uuid=c20a0653-7292-
47de-9dc1-c9c7b28fb6ee" ] } ], "mendeley" : { "formattedCitation" : "(83)", 
"plainTextFormattedCitation" : "(83)", "previouslyFormattedCitation" : "(83)" }, "properties" 
: { "noteIndex" : 0 }, "schema" : "https://github.com/citation-style-
language/schema/raw/master/csl-citation.json" }}. 
 
133p53 isoforms is not always a “marker of poor prognosis”. In serous ovarian tumours 
expressing mutant TP53, the elevated expression of 133p53 is associated to lower 
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relapse rate (43% risk reduction for recurrence) and a better survival prognostic rate (64% 
risk reduction for death). {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1038/bjc.2011.433", "ISSN" : "1532-1827", "PMID" : "22009029", 
"abstract" : "BACKGROUND: We aimed to evaluate the clinical relevance of p53 and p73 
isoforms that modulate the function of p53.\\n\\nMETHODS: This prospective multicentre 
study included 154 patients with stage III and IV serous ovarian cancer. A functional yeast-
based assay and subsequent sequencing were performed to analyse the p53 mutational 
status. Expression of p53 and p73 isoforms was determined using RT-qPCR.\\n\\nRESULTS: 
\u0394133p53 expression constituted an independent prognostic marker for recurrence-
free (hazard ratio=0.571, P=0.016, 95% CI: 0.362-0.899) and overall survival (hazard 
ratio=0.365, P=0.004, 95% CI: 0.182-0.731) in patients with p53 mutant ovarian cancer 
(n=121). High \u039440p53 expression was associated with favourable tumour grading 
(P=0.037) and improved recurrence-free survival (33.4 vs 19.6 months, P=0.029), but not 
overall survival (43.1 vs 33.6 months, P=0.139), in patients with p53 wild-type cancer (n=33). 
Neither the p53 mutational status nor p73 isoform expression possessed prognostic 
significance in the examined ovarian cancer cases.\\n\\nCONCLUSION: \u0394133p53 
expression was associated with prognosis in the vast majority of ovarian cancer cases, that 
is, patients with p53 mutant advanced serous carcinomas. Thus, our findings underline the 
importance of considering the complex p53 regulatory network.", "author" : [ { "dropping-
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5.3 40p53 
 
40p53 can directly transactivate gene and therefore does not systematically act in a 
dominant-negative manner. Overexpression of 40p53 (through the use of a lentivirus) in 
cells co-expressing p53 isoforms led to the death of WT TP53 A375 melanoma cell. This is 
interesting as melanomas, relative to other forms of cancer, have fewer TP53 mutations. 
{ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : 
"10.1038/jid.2013.391", "ISSN" : "1523-1747", "PMID" : "24037342", "abstract" : "The TP53 
gene encodes 12 distinct isoforms, some of which can alter p53 activity in the absence of 
genomic alteration. Endogenous p53 isoforms have been identified in cancers; however, the 
function of these isoforms remains unclear. In melanoma, the frequency of TP53 mutations 
is relatively low compared with other cancers, suggesting that these isoforms may have a 
larger role in regulating TP53 activity. We hypothesized that p53 function and therefore cell 
fate might be altered by the presence of \u039440p53, an embryonic isoform missing the 
first 40 N-terminal amino acids of the full-length protein including the transactivation and 
Mdm2-binding domains. To test this hypothesis, we transduced tumor and normal cells with 
a lentivirus encoding \u039440p53. We found that exogenous \u039440p53 caused 
apoptosis and increased the levels of endogenous, activated p53 in both cancerous and non-
cancerous cells, which led to significant levels of cell death, particularly in cancer cells. 
Activated p53 molecules formed nuclear heterotetramers with \u039440p53 and altered 
downstream p53 transcription target levels including p53-induced protein with death 
domain and cyclin-dependent kinase inhibitor, p21. \u039440p53 altered the promoter 
occupancy of these downstream p53 target genes in such a way that it shifted cell fate 
toward apoptosis and away from cell cycle arrest. We show that tumor suppression by p53 
can occur via an alternate route that relies on its interaction with \u039440p53.", "author" : 
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"page" : "791-800", "title" : "Dominant effects of \u039440p53 on p53 function and 
melanoma cell fate.", "type" : "article-journal", "volume" : "134" }, "uris" : [ 
"http://www.mendeley.com/documents/?uuid=98a8f6f5-ab81-4b14-8b06-9777836bce26" ] 
} ], "mendeley" : { "formattedCitation" : "(85)", "plainTextFormattedCitation" : "(85)", 
"previouslyFormattedCitation" : "(85)" }, "properties" : { "noteIndex" : 0 }, "schema" : 
"https://github.com/citation-style-language/schema/raw/master/csl-citation.json" }}  
 
Within hepatocellular cancer cells, it was noted that 40p53 is correlated with increased 
expression of FLp53, and that it promoted a senescent response in hepatocellular cancer 
cells (p21 was found to be up-regulated to a greater extent). {ADDIN CSL_CITATION { 
"citationItems" : [ { "id" : "ITEM-1", "itemData" : { "DOI" : "10.1242/jcs.190736", "ISSN" : 
"14779137", "abstract" : "Splice variants of certain genes impact on genetic biodiversity in 
mammals. The tumor suppressor TP53 gene (encoding p53) plays an important role in the 
regulation of tumorigenesis in hepatocellular carcinoma (HCC). \u039440p53\u03b1 is a 
naturally occurring p53 isoform that lacks the N-terminal transactivation domain, yet little is 
known about the role of \u039440p53\u03b1 in the development of HCC. Here, we first 
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report on the role of \u039440p53\u03b1 in HCC cell lines. In the TP53+/\u039440 cell 
clones, clonogenic activity and cell survival dramatically decreased, whereas the percentage 
of senescence-associated \u03b2-galactosidase (SA-\u03b2-gal)-positive cells and p21 (also 
known as WAF1, CIP1 and CDKN1A) expression significantly increased. These observations 
were clearly attenuated in the TP53+/\u039440 cell clones after \u039440p53\u03b1 
knockdown. In addition, exogenous \u039440p53 expression significantly suppressed cell 
growth in HCC cells with wild-type TP53, and in those that were mutant or null for TP53. 
Notably, \u039440p53\u03b1-induced tumor suppressor activity was markedly attenuated 
in cells expressing the hot-spot mutant \u039440p53\u03b1-R175H, which lacks the 
transcription factor activity of p53. Moreover, \u039440p53\u03b1 expression was 
associated with increased full-length p53 protein expression. These findings enhance the 
understanding of the molecular pathogenesis of HCC and show that \u039440p53\u03b1 
acts as an important tumor suppressor in HCC cells.", "author" : [ { "dropping-particle" : "", 
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5.4 Additional Relevant Findings 
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Within colon carcinoma, Fujita et al noted that the expression levels of p53 or 133p53 
isoform may also contribute to the progression of a tumour from a benign state to 
malignancy. Colon adenomas were associated with higher levels of p53 and reduced levels 
of 133p53. In colon carcinoma tissues, however, the inverse was witnessed, suggesting 
that varying transcription rates may play a role in the progression of cancers from a benign 
state to being malignant. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", 
"itemData" : { "DOI" : "10.1038/ncb1928", "ISBN" : "1465-7392", "ISSN" : "1476-4679", 
"PMID" : "19701195", "abstract" : "The finite proliferative potential of normal human cells 
leads to replicative cellular senescence, which is a critical barrier to tumour progression in 
vivo. We show that the human p53 isoforms Delta133p53 and p53beta function in an 
endogenous regulatory mechanism for p53-mediated replicative senescence. Induced 
p53beta and diminished Delta133p53 were associated with replicative senescence, but not 
oncogene-induced senescence, in normal human fibroblasts. The replicatively senescent 
fibroblasts also expressed increased levels of miR-34a, a p53-induced microRNA, the 
antisense inhibition of which delayed the onset of replicative senescence. The siRNA (short 
interfering RNA)-mediated knockdown of endogenous Delta133p53 induced cellular 
senescence, which was attributed to the regulation of p21(WAF1) and other p53 
transcriptional target genes. In overexpression experiments, whereas p53beta cooperated 
with full-length p53 to accelerate cellular senescence, Delta133p53 repressed miR-34a 
expression and extended the cellular replicative lifespan, providing a functional connection 
of this microRNA to the p53 isoform-mediated regulation of senescence. The senescence-
associated signature of p53 isoform expression (that is, elevated p53beta and reduced 
Delta133p53) was observed in vivo in colon adenomas with senescent phenotypes. The 
increased Delta133p53 and decreased p53beta isoform expression found in colon 
carcinoma may signal an escape from the senescence barrier during the progression from 
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Ectopic expression of the isoforms within squamous cell carcinomas of the head of the neck 
also occurs – it was established through investigation of 21 tumour samples that the 
quantity of p53β, p53γ, Δ133p53β and Δ133p53γ isoforms were elevated. 18/20 tumour 
samples recorded elevated expression of p53β; p53γ was augmented in 5 tumour samples; 
Δ133p53β in 3 and Δ133p53γ in 4. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-
1", "itemData" : { "DOI" : "10.1016/j.ejca.2006.10.019", "ISSN" : "0959-8049", "PMID" : 
"17215121", "abstract" : "Recent data indicate that, similar to p63 and p73, several different 
p53 isoforms can be produced in humans through alternative initiation of translation, usage 
of an internal promoter and alternative splicing. These isoforms are reported to have 
varying functions and expressions. In squamous cell carcinoma of the head and neck 
(SCCHN), disruption of the p53 pathway is one of the most common genetic alterations. 
However, to our knowledge, no studies regarding the expression of different p53 isoforms 
in SCCHN have so far been performed. We screened for the expression of different p53 
isoforms in SCCHN and clinically normal oral epithelia using nested RT-PCR. p53 mRNA was 
expressed in all tumours, all matched clinically normal tissue adjacent to the tumour and in 
buccal mucosa from healthy volunteers. Of the novel isoforms, p53beta was detected in the 
majority of samples analysed, and all of the recently described isoforms were also detected 
in at least some tumour and normal epithelium samples, with the exception of Deltap53 
isoforms. We conclude that p53 variant mRNAs are expressed in both normal oral stratified 
epithelium and SCCHN. Improvements in methodologies and reagents to detect and 
quantify p53 isoform expression in clinical material will be required to correlate p53 status 
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6- Clinical Applications of the p53 Isoforms – A Potential Predictive Biomarker? 
 
The utility of p53 family members in cancer diagnosis and predicting therapy response has 
been considered in recent studies. (85, 92-94). 
 
A recurring theme identified within this review is the specific abnormal expression ratio of 
p53 isoforms in certain cancers. The mechanisms with which these contribute to the 
development is still under research, but it provides a solid platform for the discussion of 
potential treatments. The differing, relative elevated expression of certain isoforms in 
diverse cancers could be used as a marker for severity. To use an example, in colon 
adenoma’s, a potential observation that levels of p53β rising and reducing levels of 
133p53 could be a clinical indicator that the tumour is progressing to malignancy and so 
treatment could be tailored accordingly to prepare for malignancy. However, the use of 
isoforms may not just be relegated to treating the outcome of abnormal expression; but 
rather, the abnormalities in the isoforms. The rectification of p53 isoform expression could 
perhaps hold the key to treating and perhaps even reversing the genesis of tumours – a 
potential example is reintroducing or promoting the transcription of p53γ in breast cancer.  
As mentioned above, p53γ improves prognosis in breast cancer patients and so research 
into how p53γ expression can be promoted and the effects it could have in vivo may be 
worthwhile and part of future studies.  
 
Having demonstrated our ability to modulate, in an inducing or inhibiting manner, the 
expression of p53 isoforms and thus the nature of p53-mediated cellular effects, the next 
step is to translate this into the clinic. The p53 isoforms present a fresh weapon in the 
arsenal of personalised medicine. Advances in methods of biopsy would allow extraction of 
a tumour sample. The collected sample would be processed via established assays involving 
techniques such as qPCR and immunostaining, allowing for characterisation of the patient’s 
‘p53 isoform status’. This information would be inputted into a modelling system to 
determine the best treatment plan in the context of the patient’s p53 isoform status, TP53 
mutation status, additional genetic background (PIK3CA, PTEN, Ras, EGFR, myc….) and stage 
of disease, among others. Treatment may include modulation of p53 isoforms for a direct 
effect via siRNA treatment (an area of intense interest) or bolstering the efficacy of 
treatments such as the conformation restoring drug APR-246.  
 
One of the major questions asked in recent times is whether the isoforms should be 
analysed one at a time, or in combination with one another. This review encapsulates that 
the p53 isoforms are not individual entities – they all combine to orchestrate the adapted 
cell response to the multiple cell signals. It is the balance of isoform expression that 
determines the fate of a cell, and so it may seem obvious that all the isoforms should be 
determined together.   
 
7- Expert Commentary:  
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TP53 mutation status does not allow to predict patient clinical outcome and to make 
treatment decision. The recent findings that p53 isoforms are associated to patient clinical 
outcome in WT and mutant TP53 patients indicate that the p53 isoforms may be the missing 
link to associate p53 status to clinical outcome. The p53 isoform expressions may be an 
indicator of the state of pluripotency and ability to resist or be sensitive to different 
treatments. The determination of p53 isoform expression in the cancer cells and tumour 
stroma may enable to define most efficient treatment (precision medicine). In this aim, it is 
essential to determine the cell signals integrated by the different p53 isoforms and how p53 
isoforms convey the cell signals to the different gene expression machineries 
(transcriptional machinery, microRNA processing machinery, splicing machinery 
(spliceosomes), translation machinery (ribosome), protein degradation machinery 
(proteasomes), protein/RNA trafficking (subcellular localisation and transport within cells), 
metabolism, paracrine signalling) to induce a cellular response precisely adapted to the cell 
context and organ function. It is a daunting task that require scientific rigor, the 
development of novel scientific tools (antibodies and cellular and animal models) and to 
work hand-in hand with clinicians to better design clinical studies. The p53 isoform specific 
antibodies currently in development and characterisation will facilitate rapid progress. 
Recently published and on-going studies making use of new p53 isoform specific antibodies 
or qPCR or RNAscope reveal the strong potential of the p53 isoforms to improve cancer 
treatment. (87, 105) 
 
8- Five Year View – The Next Step  
 
Numerous genetic factors predisposing their carriers to common disease (e.g. cancer, 
diabetes type 2, cardiovascular disease) have been reported in the specialised literature. A 
significant proportion of these factors are, in fact, polymorphic variants of genes coding for 
key proteins of DNA repair and maintenance of genomic integrity, including TP53. (95-99) 
Panels of markers for carriership of factors associated with the capacity to detect and repair 
DNA damage and for self-renewal of cell populations are currently being developed and 
tested in order to assess their applicability to assessment of risk for various diseases and 
conditions. (100-102) Different p53 isoforms combination promote different p53-mediated 
cell responses (proliferation, repair, senescence, motility, differentiation, de-differentiation, 
trans-differentiation, cell death,… ) (103). Recently, it has been proposed that alterations in 
the activity of splicing factors and in the production of key splice variants of several pivotal 
genes, including TP53, may have direct effects on cellular senescence and, respectively, the 
aging of organisms. (104) It is likely that further evidence of abnormal expression in 
isoforms should be uncovered within the next five years and discussion over how the p53 
isoforms could be used in tandem with the clinic will begin to emerge; not only for cancer, 
but with other potential clinical applications such as regenerative medicine.  
 
 
 
Key Issues 
 
 Altogether there are 12 p53 isoforms translated from 9 mRNA transcripts as a result 
of alternate promotor usage, alternative splicing and alternative initiation of 
translation. {ADDIN CSL_CITATION { "citationItems" : [ { "id" : "ITEM-1", "itemData" : 
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{ "DOI" : "10.1101/gad.1339905", "ISBN" : "2514458412", "ISSN" : "08909369", 
"PMID" : "16131611", "abstract" : "The recently discovered p53-related genes, p73 
and p63, express multiple splice variants and N-terminally truncated forms initiated 
from an alternative promoter in intron 3. To date, no alternative promoter and 
multiple splice variants have been described for the p53 gene. In this study, we show 
that p53 has a gene structure similar to the p73 and p63 genes. The human p53 gene 
contains an alternative promoter and transcribes multiple splice variants. We show 
that p53 variants are expressed in normal human tissue in a tissue-dependent 
manner. We determine that the alternative promoter is conserved through 
evolution from Drosophila to man, suggesting that the p53 family gene structure 
plays an essential role in the multiple activities of the p53 family members. 
Consistent with this hypothesis, p53 variants are differentially expressed in human 
breast tumors compared with normal breast tissue. We establish that p53beta can 
bind differentially to promoters and can enhance p53 target gene expression in a 
promoter-dependent manner, while Delta133p53 is dominant-negative toward full-
length p53, inhibiting p53-mediated apoptosis. The differential expression of the p53 
isoforms in human tumors may explain the difficulties in linking p53 status to the 
biological properties and drug sensitivity of human cancer.", "author" : [ { "dropping-
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 p53  protein consists of 7 functional domains – transactivation domains 1 and 2 
(interact with the RNA-Polymerase II transcription machinery), proline domain, DNA 
binding domain (where 90% of mutations occur), NLS, tetramerisation domain and 
DNA damage recognition domain.  
 The p53 isoforms mRNA are co-expressed in normal tissue in a tissue-dependent 
manner and eloquently explain the vast array of physiological roles that p53 
pathway is associated with.  
 The functions of the p53 isoform result from co-expression ratios (combination of 
p53 isoforms), rather than individual influence.  
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 p53 isoforms mRNA are abnormally expressed in a wide range of cancer and can be a 
useful tool as a predictive biomarker to foretell the nature of a malignancy and to 
predict response to treatment. Examples include elevated levels of 133p53 in 
many breast cancers.  
 The isoforms could thus hold potential in clinical environments, whereby association 
of certain isoforms expression/absence to certain cancers could allow for a degree of 
predictably and thus tailor treatment accordingly. 
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